[go: up one dir, main page]

TWI808279B - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDF

Info

Publication number
TWI808279B
TWI808279B TW108143269A TW108143269A TWI808279B TW I808279 B TWI808279 B TW I808279B TW 108143269 A TW108143269 A TW 108143269A TW 108143269 A TW108143269 A TW 108143269A TW I808279 B TWI808279 B TW I808279B
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
formula
polymer
alignment agent
Prior art date
Application number
TW108143269A
Other languages
Chinese (zh)
Other versions
TW202120592A (en
Inventor
黃菀婷
王建智
陳志榮
Original Assignee
奇美實業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇美實業股份有限公司 filed Critical 奇美實業股份有限公司
Priority to TW108143269A priority Critical patent/TWI808279B/en
Priority to CN202011240108.XA priority patent/CN112852446B/en
Publication of TW202120592A publication Critical patent/TW202120592A/en
Application granted granted Critical
Publication of TWI808279B publication Critical patent/TWI808279B/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)

Abstract

The present invention provides a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element. The liquid crystal alignment agent includes a polymer (A) and a solvent (B). The polymer (A) includes a first polymer (A1). The first polymer (A1) is manufactured by reacting a specific tetracarboxylic acid dianhydride component (a1) with a specific diamine component (b1). The liquid crystal alignment film is formed form the liquid crystal alignment agent, and the liquid crystal display element containing the liquid crystal alignment agent has good capability of eliminating accumulated charges after exposure to light.

Description

液晶配向劑、液晶配向膜及液晶顯示元 件 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element pieces

本發明是有關於一種液晶配向劑、液晶配向膜及液晶顯示元件,特別是關於一種利用所述液晶配向劑,以製得電荷消除耐光性佳的液晶顯示元件。 The invention relates to a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element, in particular to a liquid crystal display element with good charge elimination and light resistance by using the liquid crystal alignment agent.

用於液晶電視、液晶顯示器等的液晶顯示元件,通常在元件內部設置有控制液晶排列狀態用的液晶配向膜。目前工業上最常見的方法是以棉、尼龍、聚酯等布材沿一方向摩擦形成在電極基板上、由聚醯胺酸及/或將其醯亞胺化之聚醯亞胺所形成的膜表面,進行所謂的摩擦處理而製得此液晶配向膜。 For liquid crystal display elements used in liquid crystal televisions, liquid crystal displays, etc., a liquid crystal alignment film for controlling the alignment state of liquid crystals is usually provided inside the element. At present, the most common method in the industry is to rub cotton, nylon, polyester and other cloth materials along one direction on the surface of the film formed by polyamic acid and/or imidized polyimide on the electrode substrate, and perform so-called rubbing treatment to prepare the liquid crystal alignment film.

在液晶配向膜的配向過程中將膜表面進行摩擦處理為工業上較易於生產的方法。然而,隨著對液晶顯示元件的高效能化、高精細度化、大型化的要求越來越高,在進行摩擦處理的時候,受配向膜表面的損傷、飛塵、因機械力和靜電力所產生的影響與在配向處理面上的不均勻性等種 種的問題變得更加顯著。 During the alignment process of the liquid crystal alignment film, rubbing the surface of the film is a method that is relatively easy to produce in industry. However, as the requirements for high performance, high precision, and large-scale liquid crystal display elements are getting higher and higher, when the rubbing process is performed, damage to the surface of the alignment film, flying dust, influences due to mechanical and electrostatic forces, and unevenness on the alignment surface, etc. The problem becomes more pronounced.

做為取代摩擦處理的方法,目前已知有利用因偏光的紫外線照射而賦予液晶配向能的光配向法。所稱的光配向法之液晶配向處理是舉凡在反應機制上利用光致異構化(photoisomerization)反應的物質、利用光交聯(photocrosslink)反應的物質、利用光分解反應的物質等。再者,特開平9-297313號公報提出,光配向法使用主鏈具有環丁烷等的脂環構造的聚醯亞胺膜。使用聚醯亞胺做為光配向用配向膜的時候,因為此配向膜的耐熱性高於其他類型的配向膜,故看好此種配向膜的應用性。 As a method instead of the rubbing treatment, there is known a photo-alignment method in which alignment energy is imparted to liquid crystals by irradiation of polarized ultraviolet rays. The so-called liquid crystal alignment treatment of the photo-alignment method refers to substances that utilize photoisomerization reactions, substances that utilize photocrosslinking reactions, substances that utilize photodecomposition reactions, etc. in terms of reaction mechanism. Furthermore, JP-A-9-297313 proposes to use a polyimide film having an alicyclic structure such as cyclobutane in the main chain in the photo-alignment method. When polyimide is used as an alignment film for photo-alignment, the heat resistance of this alignment film is higher than other types of alignment films, so the applicability of this alignment film is optimistic.

光配向法為不摩擦配向處理的方法,其在工業上不僅具有利用簡單製程即可製造的優點,在橫向電場效應技術(In-Plane-Switching:IPS)驅動方式和邊界電場切換廣視角技術(Fringe Field Switching:FFS)驅動方式之液晶顯示元件中,相較於使用摩擦處理法所得的液晶配向膜,使用上述光配向法所得的液晶配向膜時,可望提升液晶顯示元件的對比度和視角特性,因此光配向法為具有前景而備受矚目的液晶配向處理方法。 The optical alignment method is a method without rubbing alignment treatment, which not only has the advantage of being able to be manufactured with a simple manufacturing process in industry, but is expected to improve the contrast and viewing angle characteristics of the liquid crystal display element when using the liquid crystal alignment film obtained by the above-mentioned optical alignment method compared with the liquid crystal alignment film obtained by the rubbing method in the drive mode of the transverse electric field effect technology (In-Plane-Switching: IPS) and the drive mode of the fringe field switching wide-viewing angle technology (Fringe Field Switching: FFS). , so the photo-alignment method is a promising liquid crystal alignment treatment method that has attracted much attention.

然而,透過光配向法所製得的液晶配向膜應用於液晶顯示元件時,仍有電荷消除耐光性不佳之問題,亦即該液晶配向膜經照光後所製得之液晶顯示元件之積蓄電荷消除緩慢,導致殘留電荷過高,進而生成殘影之問題。由上述可知,為了符合目前光配向IPS型液晶顯示器業者之要求,提供一種可形成電荷消除耐光性佳之液晶顯示元件之液 晶配向劑,為本技術領域者努力研究之目標。 However, when the liquid crystal alignment film prepared by the photo-alignment method is applied to a liquid crystal display device, there is still the problem of poor charge elimination and light resistance, that is, the accumulated charge of the liquid crystal display device manufactured after the liquid crystal alignment film is illuminated by light is eliminated slowly, resulting in excessive residual charge, and then the problem of image sticking. It can be seen from the above that in order to meet the requirements of the current photo-alignment IPS liquid crystal display industry, a liquid crystal display element capable of forming charge elimination and light fastness is provided. Crystal alignment agents are the goal of research by those skilled in the art.

本發明之一個態樣是在提供一種液晶配向劑,其包含聚合物(A)及溶劑(B)。 One aspect of the present invention is to provide a liquid crystal alignment agent, which includes a polymer (A) and a solvent (B).

本發明之另一個態樣是在提供一種液晶配向膜,其係利用上述的液晶配向劑所形成。 Another aspect of the present invention is to provide a liquid crystal alignment film, which is formed by using the above-mentioned liquid crystal alignment agent.

本發明之又一個態樣是在提供一種液晶顯示元件,其包含上述的液晶配向膜。 Another aspect of the present invention is to provide a liquid crystal display element, which includes the above-mentioned liquid crystal alignment film.

液晶配向劑Liquid crystal alignment agent

聚合物(A)Polymer (A)

本發明的聚合物(A)包含第一聚合物(A1),且第一聚合物(A1)由四羧酸二酐組份(a1)與二胺組份(b1)反應而製得。此外,聚合物(A)可選擇性地包含第二聚合物(A2)。 The polymer (A) of the present invention comprises a first polymer (A1), and the first polymer (A1) is prepared by reacting a tetracarboxylic dianhydride component (a1) with a diamine component (b1). Furthermore, the polymer (A) may optionally contain a second polymer (A2).

上述聚合物(A1)之較佳具體例為聚醯胺酸聚合物、聚醯亞胺聚合物、聚醯亞胺系嵌段共聚合物或其組台。其中,聚醯亞胺系嵌段共聚合物之較佳具體例為聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物或其任意組合。 Preferable specific examples of the aforementioned polymer (A1) are polyamic acid polymers, polyimide polymers, polyimide-based block copolymers, or combinations thereof. Among them, preferred specific examples of polyimide-based block copolymers are polyamic acid block copolymers, polyimide block copolymers, polyamic acid-polyimide block copolymers, or any combination thereof.

第一聚合物(A1)First polymer (A1)

四羧酸二酐組份(a1)Tetracarboxylic dianhydride component (a1)

四羧酸二酐化合物(a1-1)Tetracarboxylic dianhydride compound (a1-1)

本發明之四羧酸二酐組份(a1)包含至少一種四 羧酸二酐化合物(a1-1),其具有如下式(I)所示的結構: The tetracarboxylic dianhydride component (a1) of the present invention comprises at least one tetracarboxylic Carboxylic acid dianhydride compound (a1-1), which has a structure shown in the following formula (I):

Figure 108143269-A0101-12-0004-1
Figure 108143269-A0101-12-0004-1

於式(I)中,R1至R4各自獨立地代表氫原子、鹵素原子、碳數為1至6的烷基、碳數為2至6的烯基、碳數為2至6的炔基、含有氟原子且碳數為1至6的一價有機基團或苯基,R1至R4可為相同或不同,且R1、R2、R3及R4之至少一者不為氫原子。 In formula (I), R 1 to R 4 each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group containing fluorine atoms and having 1 to 6 carbon atoms, or a phenyl group, R 1 to R 4 may be the same or different, and at least one of R 1 , R 2 , R 3 and R 4 is not a hydrogen atom.

在R1、R2、R3及R4具有立體障礙結構的情況下,會造成液晶配向劑的液晶配向性不佳。因此,R1、R2、R3及R4較佳為氫原子、甲基或乙基,其中又以甲基為更佳。 When R 1 , R 2 , R 3 and R 4 have a steric barrier structure, the liquid crystal alignment of the liquid crystal alignment agent will be poor. Therefore, R 1 , R 2 , R 3 and R 4 are preferably hydrogen atoms, methyl or ethyl, among which methyl is more preferred.

式(I)所示結構的四羧酸二酐化合物(a1-1)的具體例子可例如為下式(I-1)至式(I-8)所示的化合物。針對液晶配向性而言,以式(I-1)為較佳。 Specific examples of the tetracarboxylic dianhydride compound (a1-1) having the structure represented by formula (I) may be, for example, compounds represented by the following formula (I-1) to formula (I-8). For liquid crystal alignment, formula (I-1) is preferred.

Figure 108143269-A0101-12-0004-2
Figure 108143269-A0101-12-0004-2

Figure 108143269-A0101-12-0005-3
Figure 108143269-A0101-12-0005-3

上述之四羧酸二酐化合物(a1-1)可以單獨一種使用或者混合複數種使用。 The said tetracarboxylic dianhydride compound (a1-1) can be used individually by 1 type or in mixture of plural types.

基於四羧酸二酐組份(a1)的總使用量為100莫耳,四羧酸二酐化合物(a1-1)的使用量為20莫耳至100莫耳,較佳為30莫耳至100莫耳,然以40莫耳至100莫耳為更佳。 Based on the total usage amount of the tetracarboxylic dianhydride component (a1) being 100 moles, the usage amount of the tetracarboxylic dianhydride compound (a1-1) is 20 moles to 100 moles, preferably 30 moles to 100 moles, and more preferably 40 moles to 100 moles.

若四羧酸二酐組份(a1)不包含四羧酸二酐化合物(a1-1)時,所製得之液晶顯示元件具有電荷消除耐光性不佳之缺陷。 If the tetracarboxylic dianhydride component (a1) does not contain the tetracarboxylic dianhydride compound (a1-1), the resulting liquid crystal display device has the defect of poor charge elimination and light resistance.

其他四羧酸二酐化合物(a1-2)Other tetracarboxylic dianhydride compounds (a1-2)

本發明之四羧酸二酐組份(a1)可進一步包含其他四羧酸二酐化合物(a1-2)。其他四羧酸二酐化合物(a1-2) 較佳具體例為(1)脂肪族四羧酸二酐化合物、(2)脂環族四羧酸二酐化合物、(3)芳香族四羧酸二酐化合物或(4)具有式(1-1)至式(1-6)所示之四羧酸二酐化合物等。 The tetracarboxylic dianhydride component (a1) of the present invention may further contain other tetracarboxylic dianhydride compounds (a1-2). Other tetracarboxylic dianhydride compounds (a1-2) Preferred specific examples are (1) aliphatic tetracarboxylic dianhydride compounds, (2) alicyclic tetracarboxylic dianhydride compounds, (3) aromatic tetracarboxylic dianhydride compounds, or (4) tetracarboxylic dianhydride compounds represented by formulas (1-1) to (1-6).

本發明之(1)脂肪族四羧酸二酐化合物包含但不限於乙烷四羧酸二酐或丁烷四羧酸二酐等之脂肪族四羧酸二酐化合物。 The (1) aliphatic tetracarboxylic dianhydride compound of the present invention includes, but not limited to, aliphatic tetracarboxylic dianhydride compounds such as ethane tetracarboxylic dianhydride or butane tetracarboxylic dianhydride.

本發明之(2)脂環族四羧酸二酐化合物包含但不限於1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3',4,4'-二環己基四羧酸二酐、順-3,7-二丁基環庚基-1,5-二烯-1,2,5,6-四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐或二環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐等之脂環族四羧酸二酐化合物。 The (2) alicyclic tetracarboxylic dianhydride compound of the present invention includes but not limited to 1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2 ,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic dianhydride, 1,2,4,5-cyclohexane tetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyl tetracarboxylic dianhydride, cis-3,7-dibutylcycloheptyl-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic dianhydride or bicyclo[2 .2.2] Alicyclic tetracarboxylic dianhydride compounds such as -oct-7-ene-2,3,5,6-tetracarboxylic dianhydride.

本發明之(3)芳香族四羧酸二酐化合物之具體例可包含但不限於3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、2,2',3,3'-二苯甲酮四羧酸二酐、3,3',4,4'-二苯甲酮四羧酸二酐、3,3',4,4'-聯苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3'-4,4'-二苯基乙烷四羧酸二酐、3,3',4,4'-二甲基二苯基矽烷四羧酸二酐、3,3',4,4'-四苯基矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、2,3,3',4'-二苯醚四羧酸二酐、3,3',4,4'-二苯醚四羧酸二酐、4,4'-雙(3,4-二羧基苯氧基) 二苯硫醚二酐、2,3,3',4'-二苯硫醚四羧酸二酐、3,3',4,4'-二苯硫醚四羧酸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯碸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯丙烷二酐、3,3',4,4'-全氟異亞丙基二苯二酸二酐、2,2',3,3'-二苯基四羧酸二酐、2,3,3',4'-二苯基四羧酸二酐、3,3',4,4'-二苯基四羧酸二酐、雙(苯二酸)苯膦氧化物二酐、對-伸苯基-雙(三苯基苯二酸)二酐、間-伸苯基-雙(三苯基苯二酸)二酐、雙(三苯基苯二酸)-4,4'-二苯基醚二酐、雙(三苯基苯二酸)-4,4'-二苯基甲烷二酐、乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)、2,3,4,5-四氫呋喃四羧酸二酐、1,3,3a,4,5,9b-六氫-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氫-5,8-二甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、5-(2,5-二側氧基四氫呋喃基)-3-甲基-3-環己烯-1,2-二羧酸二酐等。 Specific examples of (3) aromatic tetracarboxylic dianhydride compounds of the present invention may include, but are not limited to, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 2,2',3,3'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-biphenylene tetracarboxylic dianhydride, 1,4 ,5,8-naphthalene tetracarboxylic dianhydride, 2,3,6,7-naphthalene tetracarboxylic dianhydride, 3,3'-4,4'-diphenylethane tetracarboxylic dianhydride, 3,3',4,4'-dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3',4,4'-tetraphenylsilane tetracarboxylic dianhydride, 1,2,3,4-furan tetracarboxylic dianhydride, 2,3,3',4'-diphenyl ether tetracarboxylic dianhydride , 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy) Diphenyl sulfide dianhydride, 2,3,3',4'-diphenyl sulfide tetracarboxylic dianhydride, 3,3',4,4'-diphenyl sulfide tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylene dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropylidene diphthalic dianhydride, 2,2 ',3,3'-diphenyltetracarboxylic dianhydride, 2,3,3',4'-diphenyltetracarboxylic dianhydride, 3,3',4,4'-diphenyltetracarboxylic dianhydride, bis(phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, m-phenylene-bis(triphenylphthalic acid) dianhydride, bis(triphenylphthalic acid)-4,4'-diphenylether dianhydride, bis(triphenylphthalic acid) -4,4'-diphenylmethane dianhydride, ethylene glycol-bis(dehydrated trimellitate), propylene glycol-bis(dehydrated trimellitate), 1,4-butanediol-bis(dehydrated trimellitate), 1,6-hexanediol-bis(dehydrated trimellitate), 1,8-octanediol-bis(dehydrated trimellitate), 2,2-bis(4-hydroxyphenyl)propane-bis(dehydrated trimellitate), 2,3, 4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-methyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c] -furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-ethyl-5-(tetrahydro-2,5-dipentoxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-methyl-5-(tetrahydro-2,5-dipentoxy-3-furyl)-naphtho[1,2- c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-ethyl-5-(tetrahydro-2,5-dipentoxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-methyl-5-(tetrahydro-2,5-dipentoxy-3-furyl)-naphtho[1, 2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-ethyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 5-(2,5-dioxotetrahydrofuranyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, etc.

根據本發明之(4)具有如式(1-1)至式(1-6)所示之四羧酸二酐化合物,詳細敘述如下。 (4) according to the present invention has a tetracarboxylic dianhydride compound represented by formula (1-1) to formula (1-6), and is described in detail as follows.

Figure 108143269-A0101-12-0008-4
Figure 108143269-A0101-12-0008-4

Figure 108143269-A0101-12-0008-5
Figure 108143269-A0101-12-0008-5

Figure 108143269-A0101-12-0008-6
Figure 108143269-A0101-12-0008-6

Figure 108143269-A0101-12-0009-7
Figure 108143269-A0101-12-0009-7

於式(1-5)中,A1代表含有芳香環的二價基團;r代表1至2的整數;A2及A3可為相同或不同,且可分別代表氫原子或烷基。較佳地,如式(1-5)所示之四羧酸二酐化合物可選自於如下式(1-5-1)至式(1-5-3)所示之化合物。 In formula (1-5), A 1 represents a divalent group containing an aromatic ring; r represents an integer from 1 to 2; A 2 and A 3 may be the same or different, and may represent a hydrogen atom or an alkyl group respectively. Preferably, the tetracarboxylic dianhydride compound shown in formula (1-5) can be selected from the compounds shown in formula (1-5-1) to formula (1-5-3).

Figure 108143269-A0101-12-0009-8
Figure 108143269-A0101-12-0009-8

Figure 108143269-A0101-12-0009-9
Figure 108143269-A0101-12-0009-9

Figure 108143269-A0101-12-0009-10
Figure 108143269-A0101-12-0009-10

於式(1-6)中,A4代表含有芳香環的二價基 團;A5及A6可為相同或不同,且分別地代表氫原子或烷基。較佳地,如式(1-6)所示之四羧酸二酐化合物可選自於如下式(1-6-1)所示之化合物。 In formula (1-6), A 4 represents a divalent group containing an aromatic ring; A 5 and A 6 may be the same or different, and represent a hydrogen atom or an alkyl group respectively. Preferably, the tetracarboxylic dianhydride compound represented by the formula (1-6) can be selected from the compounds represented by the following formula (1-6-1).

Figure 108143269-A0101-12-0010-11
Figure 108143269-A0101-12-0010-11

上述之其他四羧酸二酐化合物(a1-2)可以單獨一種使用或者混合複數種使用。 The other tetracarboxylic dianhydride compound (a1-2) mentioned above can be used individually by 1 type or in mixture of plural types.

基於四羧酸二酐組份(a1)的總使用量為100莫耳,其他四羧酸二酐化合物(a1-2)的使用量為0莫耳至80莫耳,較佳為0莫耳至70莫耳,然以0莫耳至60莫耳為更佳。 Based on the total usage of the tetracarboxylic dianhydride component (a1) being 100 moles, the usage of other tetracarboxylic dianhydride compounds (a1-2) is from 0 moles to 80 moles, preferably from 0 moles to 70 moles, and more preferably from 0 moles to 60 moles.

基於二胺組份(b1)之使用量為100莫耳,四羧酸二酐組份(a1)使用量範圍為20莫耳至200莫耳;較佳為30莫耳至120莫耳。 Based on 100 moles of the diamine component (b1), the usage amount of the tetracarboxylic dianhydride component (a1) ranges from 20 moles to 200 moles; preferably 30 moles to 120 moles.

二胺組份(b1)Diamine component (b1)

二胺化合物(b1-1)Diamine compound (b1-1)

本發明之二胺組份(b1)包含至少一種二胺化合物(b1-1),其具有如下式(II)所示的結構: The diamine component (b1) of the present invention comprises at least one diamine compound (b1-1), which has the structure shown in the following formula (II):

Figure 108143269-A0101-12-0010-13
Figure 108143269-A0101-12-0010-13

於式(II)中,X1代表O、COO、OCO、CONH或NHCO;環X2代表苯環或環己烷;且X3代表碳數為1至10的直鏈烷基或碳數為3至10的支鏈烷基。 In formula (II ) , X 1 represents O, COO, OCO, CONH or NHCO; Ring X 2 represents a benzene ring or cyclohexane;

具體而言,上述具有式(II)之結構的二胺化合 物(b1-1)可例如為下式(2-1)至式(2-35)所示的化合物: Specifically, the above-mentioned diamine compound having the structure of formula (II) Compound (b1-1) can be, for example, compounds represented by the following formula (2-1) to formula (2-35):

Figure 108143269-A0101-12-0011-15
Figure 108143269-A0101-12-0011-15

Figure 108143269-A0101-12-0011-16
Figure 108143269-A0101-12-0011-16

Figure 108143269-A0101-12-0011-17
Figure 108143269-A0101-12-0011-17

Figure 108143269-A0101-12-0011-18
Figure 108143269-A0101-12-0011-18

Figure 108143269-A0101-12-0011-19
Figure 108143269-A0101-12-0011-19

Figure 108143269-A0101-12-0011-20
Figure 108143269-A0101-12-0011-20

Figure 108143269-A0101-12-0011-21
Figure 108143269-A0101-12-0011-21

Figure 108143269-A0101-12-0012-22
Figure 108143269-A0101-12-0012-22

Figure 108143269-A0101-12-0012-23
Figure 108143269-A0101-12-0012-23

Figure 108143269-A0101-12-0012-24
Figure 108143269-A0101-12-0012-24

Figure 108143269-A0101-12-0012-25
Figure 108143269-A0101-12-0012-25

Figure 108143269-A0101-12-0012-26
Figure 108143269-A0101-12-0012-26

Figure 108143269-A0101-12-0012-27
Figure 108143269-A0101-12-0012-27

Figure 108143269-A0101-12-0012-28
Figure 108143269-A0101-12-0012-28

Figure 108143269-A0101-12-0013-29
Figure 108143269-A0101-12-0013-29

Figure 108143269-A0101-12-0013-36
Figure 108143269-A0101-12-0013-36

Figure 108143269-A0101-12-0013-31
Figure 108143269-A0101-12-0013-31

Figure 108143269-A0101-12-0013-32
Figure 108143269-A0101-12-0013-32

Figure 108143269-A0101-12-0013-33
Figure 108143269-A0101-12-0013-33

Figure 108143269-A0101-12-0013-34
Figure 108143269-A0101-12-0013-34

Figure 108143269-A0101-12-0013-35
Figure 108143269-A0101-12-0013-35

Figure 108143269-A0101-12-0014-38
Figure 108143269-A0101-12-0014-38

Figure 108143269-A0101-12-0014-39
Figure 108143269-A0101-12-0014-39

Figure 108143269-A0101-12-0014-40
Figure 108143269-A0101-12-0014-40

Figure 108143269-A0101-12-0014-41
Figure 108143269-A0101-12-0014-41

Figure 108143269-A0101-12-0014-42
Figure 108143269-A0101-12-0014-42

Figure 108143269-A0101-12-0014-37
Figure 108143269-A0101-12-0014-37

Figure 108143269-A0101-12-0015-44
Figure 108143269-A0101-12-0015-44

Figure 108143269-A0101-12-0015-45
Figure 108143269-A0101-12-0015-45

Figure 108143269-A0101-12-0015-46
Figure 108143269-A0101-12-0015-46

Figure 108143269-A0101-12-0015-47
Figure 108143269-A0101-12-0015-47

Figure 108143269-A0101-12-0015-48
Figure 108143269-A0101-12-0015-48

Figure 108143269-A0101-12-0015-49
Figure 108143269-A0101-12-0015-49

Figure 108143269-A0101-12-0015-43
Figure 108143269-A0101-12-0015-43

Figure 108143269-A0101-12-0016-50
Figure 108143269-A0101-12-0016-50

前述二胺化合物(b1-1)可單獨一種使用或混合複數種使用。 The said diamine compound (b1-1) can be used individually by 1 type or in mixture of several types.

基於二胺組份(b1)的總使用量為100莫耳,二胺化合物(b1-1)的使用量為1莫耳至20莫耳,較佳為1莫耳至15莫耳,然以1莫耳至10莫耳為更佳。 Based on the total usage amount of the diamine component (b1) being 100 moles, the usage amount of the diamine compound (b1-1) is 1 to 20 moles, preferably 1 to 15 moles, and more preferably 1 to 10 moles.

倘若液晶配向劑中之二胺組份(b1)未使用二胺化合物(b1-1),則所形成的液晶顯示元件的電荷消除耐光性不佳。 If the diamine component (b1) in the liquid crystal alignment agent does not use the diamine compound (b1-1), the formed liquid crystal display device will have poor charge elimination and light resistance.

此外,若式(II)中之X3代表碳數為3至10的支鏈烷基,則可進一步提升所形成的液晶顯示元件的電荷消除耐光性。 In addition, if X 3 in the formula (II) represents a branched chain alkyl group having 3 to 10 carbon atoms, the charge-eliminating light resistance of the formed liquid crystal display device can be further improved.

其他二胺化合物(b1-2)Other diamine compounds (b1-2)

本發明之二胺組份(b1)可進一步包含其他二胺化合物(b1-2)。 The diamine component (b1) of the present invention may further contain other diamine compounds (b1-2).

其他二胺化合物(b1-2)可包含但不限於1,2-二胺基乙烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、4,4'-二胺基庚烷、1,3-二胺基-2,2-二甲基丙烷、1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二胺基-5-甲基壬烷、 2,11-二胺基十二烷、1,12-二胺基十八烷、1,2-雙(3-胺基丙氧基)乙烷、4,4'-二胺基二環己基甲烷、4,4'-二胺基-3,3'-二甲基二環己基胺、1,3-二胺基環己烷、1,4-二胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、三環(6.2.1.02,7)-十一碳烯二甲基二胺、4,4'-亞甲基雙(環己基胺)、4,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基乙烷、4,4'-二胺基二苯基碸、4,4'-二胺基苯甲醯苯胺、4,4'-二胺基二苯基醚、3,4'-二胺基二苯基醚、1,5-二胺基萘、5-胺基-1-(4'-胺基苯基)-1,3,3-三甲基氫茚、6-胺基-1-(4'-胺基苯基)-1,3,3-三甲基氫茚、六氫-4,7-甲橋伸氫茚基二亞甲基二胺、3,3'-二胺基二苯甲酮、3,4'-二胺基二苯甲酮、4,4'-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)環己烷、1,5-雙(4-胺基苯氧基亞甲基)金剛烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯基)-10-氫蒽、9,10-雙(4-胺基苯基)蒽[9,10-bis(4-aminophenyl)anthracene]、2,7-二胺基茀、9,9-雙(4-胺基苯基)茀、4,4'-亞甲基-雙(2-氯苯胺)、4,4'-(對-伸苯基異亞丙基)雙苯胺、4,4'-(間-伸苯基異亞丙基)雙苯胺、2,2'-雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4'-雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯{5-[4-(4-n-pentylcyclohexyl) cyclohexyl]phenylmethylene-1,3-diaminobenzene}、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethyl phenyl)cyclohexane}或如下式(3-1)至式(3-29)所示之其他二胺化合物。 Other diamine compounds (b1-2) may include, but are not limited to, 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,10-diaminodecane, 4,4'-diaminoheptane, 1,3- Diamino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1,7-diamino-2,5-dimethylheptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1,9-diamino-5-methylnonane, 2,11-diaminododecane, 1,12-diaminooctadecane, 1,2-bis(3-aminopropoxy)ethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diamino-3,3'-dimethyldicyclohexylamine, 1,3-diaminocyclohexane, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadienediamine, tricyclic (6.2. 1.02,7)-undecenedimethyldiamine, 4,4'-methylene bis(cyclohexylamine), 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4'-diaminodiphenylene, 4,4'-diaminobenzamide, 4,4'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 5-amine 1-(4'-aminophenyl)-1,3,3-trimethylhydroindene, 6-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydroindene, hexahydro-4,7-methyleneindenyl dimethylenediamine, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4'-diaminobenzophenone, 2,2-bis[4-(4-aminophenyl oxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenoxy)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]pyridine, 1,4-bis(4-aminophenoxy)cyclohexane, 1,5-bis(4-aminophenoxymethylene)adamantane, 1,4-bis(4-aminophenoxy)benzene, 1,3- Bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 9,10-bis(4-aminophenyl)anthracene [9,10-bis(4-aminophenyl)anthracene], 2,7-diaminophenylene, 9,9-bis(4-aminophenyl) fluorine, 4,4'-methylene-bis(2-chloro Aniline), 4,4'-(p-phenyleneisopropylidene)bisaniline, 4,4'-(m-phenyleneisopropylidene)bisaniline, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene- 1,3-Diaminobenzene{5-[4-(4-n-pentylcyclohexyl) cyclohexyl]phenylmethylene-1,3-diaminobenzene}, 1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane} or others shown in the following formula (3-1) to formula (3-29) diamine compound.

Figure 108143269-A0101-12-0018-51
Figure 108143269-A0101-12-0018-51

於式(3-1)中,Z1代表-O-、

Figure 108143269-A0101-12-0018-54
Figure 108143269-A0101-12-0018-57
Figure 108143269-A0101-12-0018-58
Figure 108143269-A0101-12-0018-59
Figure 108143269-A0101-12-0018-61
,且Z2代表含甾基團、三氟甲基、氟基、碳數為2至30之烷基或衍生自吡啶、嘧啶、三嗪、哌啶及哌嗪等含氮原子環狀結構的一價基團。 In formula (3-1), Z 1 represents -O-,
Figure 108143269-A0101-12-0018-54
,
Figure 108143269-A0101-12-0018-57
,
Figure 108143269-A0101-12-0018-58
,
Figure 108143269-A0101-12-0018-59
or
Figure 108143269-A0101-12-0018-61
, and Z represents a sterol-containing group, a trifluoromethyl group, a fluoro group, an alkyl group with a carbon number of 2 to 30, or a monovalent group derived from a nitrogen-atom-containing ring structure such as pyridine, pyrimidine, triazine, piperidine, and piperazine.

上式(3-1)所示之其他二胺化合物較佳可為2,4-二胺基苯基甲酸乙酯(2,4-diaminophenyl ethyl formate)、3,5-二胺基苯基甲酸乙酯(3,5-diaminophenyl ethyl formate)、2,4-二胺基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二胺基苯基甲酸丙酯(3,5-diaminophenyl propyl formate)、1-十二烷氧基-2,4-二胺基苯(1-dodecoxy-2,4-diamino-benzene)、1-十六烷氧基-2,4-二胺基苯(1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)或下式(3-1-1)至 式(3-1-6)所示之其他二胺化合物。 Other diamine compounds represented by the above formula (3-1) are preferably 2,4-diaminophenyl ethyl formate (2,4-diaminophenyl ethyl formate), 3,5-diaminophenyl ethyl formate (3,5-diaminophenyl ethyl formate), 2,4-diaminophenyl propyl formate (2,4-diaminophenyl propyl formate), 3,5-diaminophenyl formic acid propyl formate (3, or (3-1-1) to Other diamine compounds represented by formula (3-1-6).

Figure 108143269-A0101-12-0019-62
Figure 108143269-A0101-12-0019-62

Figure 108143269-A0101-12-0019-63
Figure 108143269-A0101-12-0019-63

Figure 108143269-A0101-12-0019-64
Figure 108143269-A0101-12-0019-64

Figure 108143269-A0101-12-0019-65
Figure 108143269-A0101-12-0019-65

Figure 108143269-A0101-12-0019-66
Figure 108143269-A0101-12-0019-66

Figure 108143269-A0101-12-0020-67
Figure 108143269-A0101-12-0020-67

Figure 108143269-A0101-12-0020-68
Figure 108143269-A0101-12-0020-68

於式(3-2)中,Z3代表-O-、

Figure 108143269-A0101-12-0020-69
Figure 108143269-A0101-12-0020-70
Figure 108143269-A0101-12-0020-71
Figure 108143269-A0101-12-0020-72
Figure 108143269-A0101-12-0020-73
,Z4及Z5代表伸脂肪族環、伸芳香族環或伸雜環基團,且Z6代表碳數為3至18之烷基、碳數為3至18之烷氧基、碳數為1至5之氟烷基、碳數為1至5之氟烷氧基、氰基或鹵素原子。 In formula (3-2), Z 3 represents -O-,
Figure 108143269-A0101-12-0020-69
,
Figure 108143269-A0101-12-0020-70
,
Figure 108143269-A0101-12-0020-71
,
Figure 108143269-A0101-12-0020-72
or
Figure 108143269-A0101-12-0020-73
, Z4 and Z5 represent extended aliphatic ring, extended aromatic ring or heterocyclic group, and Z6 represents an alkyl group with a carbon number of 3 to 18, an alkoxy group with a carbon number of 3 to 18, a fluoroalkyl group with a carbon number of 1 to 5, a fluoroalkoxy group with a carbon number of 1 to 5, a cyano group or a halogen atom.

上式(3-2)所示之其他二胺化合物較佳可為如下式(3-2-1)至式(3-2-13)所示之二胺化合物: Other diamine compounds represented by the above formula (3-2) are preferably diamine compounds represented by the following formulas (3-2-1) to (3-2-13):

Figure 108143269-A0101-12-0020-74
Figure 108143269-A0101-12-0020-74

Figure 108143269-A0101-12-0020-75
Figure 108143269-A0101-12-0020-75

Figure 108143269-A0101-12-0021-77
Figure 108143269-A0101-12-0021-77

Figure 108143269-A0101-12-0021-78
Figure 108143269-A0101-12-0021-78

Figure 108143269-A0101-12-0021-79
Figure 108143269-A0101-12-0021-79

Figure 108143269-A0101-12-0021-80
Figure 108143269-A0101-12-0021-80

Figure 108143269-A0101-12-0021-81
Figure 108143269-A0101-12-0021-81

Figure 108143269-A0101-12-0021-82
Figure 108143269-A0101-12-0021-82

Figure 108143269-A0101-12-0021-85
Figure 108143269-A0101-12-0021-85

Figure 108143269-A0101-12-0021-86
Figure 108143269-A0101-12-0021-86

Figure 108143269-A0101-12-0021-76
Figure 108143269-A0101-12-0021-76

Figure 108143269-A0101-12-0022-87
Figure 108143269-A0101-12-0022-87

Figure 108143269-A0101-12-0022-88
Figure 108143269-A0101-12-0022-88

於式(3-2-10)至式(3-2-13)中,s可代表3至12的整數。 In formula (3-2-10) to formula (3-2-13), s may represent an integer of 3 to 12.

Figure 108143269-A0101-12-0022-89
Figure 108143269-A0101-12-0022-89

於式(3-3)中,Z7代表氫原子、碳數為1至5的醯基、碳數為1至5的烷基、碳數為1至5的烷氧基或鹵素。P1代表1至3的整數。當P1大於1時,複數個Z7可為相同或不同。 In formula (3-3), Z 7 represents a hydrogen atom, an acyl group with 1 to 5 carbons, an alkyl group with 1 to 5 carbons, an alkoxy group with 1 to 5 carbons, or a halogen. P1 represents an integer of 1 to 3. When P1 is greater than 1, the plurality of Z 7 may be the same or different.

上述式(3-3)所示之二胺化合物較佳係選自於(1)P1為1:對-二胺苯、間-二胺苯、鄰-二胺苯或2,5-二胺甲苯等;(2)P1為2:4,4'-二胺基聯苯、2,2'-二甲基-4,4'-二胺基聯苯、3,3'-二甲基-4,4'-二胺基聯苯、3,3'-二甲氧基-4,4'-二胺基聯苯、2,2'-二氯-4,4'-二胺基聯苯、3,3'-二氯-4,4'-二胺基聯苯、2,2',5,5'-四氯-4,4'-二胺基聯苯、2,2'-二氯-4,4'-二胺基-5,5'-二甲氧基聯苯或4,4'-二胺基-2,2'-雙(三氟甲基)聯苯等;(3)P1為3:1,4-雙(4'-胺基苯基)苯等,更佳係選自於對-二胺苯、2,5-二胺甲苯、4,4'-二胺基聯苯、3,3'-二甲氧基-4,4'-二胺基聯苯或1,4-雙(4'-胺基苯基)苯。 The diamine compound represented by the above formula (3-3) is preferably selected from (1) P1 is 1: p-diaminobenzene, m-diaminobenzene, o-diaminobenzene or 2,5-diaminotoluene, etc.; (2) P1 is 2: 4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4, 4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diaminobiphenyl, 3,3'-dichloro-4,4'-diaminobiphenyl, 2,2',5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl or 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, etc.; (3) P1 is 3: 1,4-bis(4'-aminophenyl)benzene, etc., more preferably selected from p-diaminobenzene, 2,5-diaminotoluene, 4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl or 1,4-bis(4'-aminophenyl)benzene.

Figure 108143269-A0101-12-0023-90
Figure 108143269-A0101-12-0023-90

於上式(3-4)中,P2代表1至5的整數。式(3-4)所示之結構較佳係選自於4,4'-二胺基二苯基硫醚。 In the above formula (3-4), P2 represents an integer of 1 to 5. The structure represented by formula (3-4) is preferably selected from 4,4'-diaminodiphenyl sulfide.

Figure 108143269-A0101-12-0023-91
Figure 108143269-A0101-12-0023-91

於式(3-5)中,Z8及Z10可為相同或不同,且分別代表二價有機基團,Z9代表衍生自吡啶、嘧啶、三嗪、哌啶及哌嗪等含氮原子環狀結構的二價基團。 In formula (3-5), Z 8 and Z 10 may be the same or different, and represent divalent organic groups respectively, and Z 9 represents divalent groups derived from ring structures containing nitrogen atoms such as pyridine, pyrimidine, triazine, piperidine and piperazine.

Figure 108143269-A0101-12-0023-92
Figure 108143269-A0101-12-0023-92

於式(3-6)中,Z11、Z12、Z13及Z14分別可為相同或不同,且可代表碳數為1至12的烴基。P3代表1至3的整數,且P4代表1至20的整數。 In formula (3-6), Z 11 , Z 12 , Z 13 and Z 14 may be the same or different, and may represent a hydrocarbon group with 1 to 12 carbons. P3 represents an integer of 1 to 3, and P4 represents an integer of 1 to 20.

Figure 108143269-A0101-12-0023-93
Figure 108143269-A0101-12-0023-93

於式(3-7)中,Z15代表-O-或伸環己烷基,Z16代表-CH2-,Z17代表伸苯基或伸環己烷基,且Z18代表氫原子或庚基。 In formula (3-7), Z 15 represents -O- or cyclohexylene, Z 16 represents -CH 2 -, Z 17 represents phenylene or cyclohexylene, and Z 18 represents a hydrogen atom or heptyl.

上式(3-7)所示之二胺化合物較佳係選自於如下式(3-7-1)及式(3-7-2)所示之二胺化合物。 The diamine compound represented by the above formula (3-7) is preferably selected from the diamine compounds represented by the following formula (3-7-1) and formula (3-7-2).

Figure 108143269-A0101-12-0024-94
Figure 108143269-A0101-12-0024-94

Figure 108143269-A0101-12-0024-95
Figure 108143269-A0101-12-0024-95

式(3-8)至式(3-29)所示之其他二胺化合物如下所示: Other diamine compounds represented by formula (3-8) to formula (3-29) are as follows:

Figure 108143269-A0101-12-0024-96
Figure 108143269-A0101-12-0024-96

Figure 108143269-A0101-12-0024-97
Figure 108143269-A0101-12-0024-97

Figure 108143269-A0101-12-0025-104
Figure 108143269-A0101-12-0025-104

Figure 108143269-A0101-12-0026-106
Figure 108143269-A0101-12-0026-106

Figure 108143269-A0101-12-0026-107
Figure 108143269-A0101-12-0026-107

Figure 108143269-A0101-12-0026-108
Figure 108143269-A0101-12-0026-108

Figure 108143269-A0101-12-0026-109
Figure 108143269-A0101-12-0026-109

Figure 108143269-A0101-12-0026-110
Figure 108143269-A0101-12-0026-110

Figure 108143269-A0101-12-0026-111
Figure 108143269-A0101-12-0026-111

Figure 108143269-A0101-12-0026-112
Figure 108143269-A0101-12-0026-112

Figure 108143269-A0101-12-0026-113
Figure 108143269-A0101-12-0026-113

Figure 108143269-A0101-12-0026-105
Figure 108143269-A0101-12-0026-105

Figure 108143269-A0101-12-0027-114
Figure 108143269-A0101-12-0027-114

於式(3-16)至式(3-19)中,Z19較佳係碳數為1至10之烷基或碳數為1至10之烷氧基。於式(3-20)至式(3-24)中,Z20較佳為氫原子、碳數為1至10之烷基或碳數為1至10之烷氧基。 In formula (3-16) to formula (3-19), Z 19 is preferably an alkyl group having 1 to 10 carbons or an alkoxy group having 1 to 10 carbons. In formula (3-20) to formula (3-24), Z 20 is preferably a hydrogen atom, an alkyl group with 1 to 10 carbons or an alkoxy group with 1 to 10 carbons.

其他二胺化合物(b1-2)較佳可包含但不限於1,2-二胺基乙烷、4,4'-二胺基二環己基甲烷、4,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基醚、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯、1,3-雙(3-胺基苯氧基)苯、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷、2,4-二胺基苯基甲酸乙酯、對-二胺苯、間-二胺苯、鄰-二胺苯、式(3-1-1)、式(3-1-2)、式(3-1-5)、式(3-2-1)、式(3-2-11)、式(3-7-1)、式(3-25)或式(3-28)所表示的化合物。 Other diamine compounds (b1-2) preferably include but are not limited to 1,2-diaminoethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene, 1,3-bis(3-aminophenoxy)benzene, 1,1-bis[4 -(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane, ethyl 2,4-diaminobenzoate, p-diaminobenzene, m-diaminobenzene, o-diaminobenzene, formula (3-1-1), formula (3-1-2), formula (3-1-5), formula (3-2-1), formula (3-2-11), formula (3-7-1), formula (3-25) or formula (3- 28) The compound represented.

前述之二胺組份(b1)中的其他二胺化合物(b1-2)可單獨一種或混合複數種使用。 The other diamine compounds (b1-2) in the aforementioned diamine component (b1) can be used alone or in combination.

基於二胺組份(b1)的總使用量為100莫耳,其他二胺化合物(b1-2)的使用量為80莫耳至99莫耳,較佳為85莫耳至99莫耳,然以90莫耳至99莫耳為更佳。 Based on the total amount of diamine component (b1) being 100 moles, the amount of other diamine compounds (b1-2) is 80 to 99 moles, preferably 85 to 99 moles, and more preferably 90 to 99 moles.

第一聚合物(A1)的製備方法The preparation method of the first polymer (A1)

本發明之聚醯胺酸聚合物之製備可為一般之方法,較佳地,前述聚醯胺酸聚合物之製備方法包含以下步 驟:將包含四羧酸二酐組份(a1)與二胺組份(b1)之混合物溶於溶劑中,在0℃至100℃之溫度條件下進行聚縮合反應並反應1小時至24小時,接著再將上述之反應溶液以蒸發器進行減壓蒸餾方式,即可得到聚醯胺酸聚合物,或者將上述之反應溶液倒入大量之貧溶劑中,得到一析出物,接著經由減壓乾燥方式將前述析出物進行乾燥處理,即可得到聚醯胺酸聚合物。 The preparation of polyamic acid polymer of the present invention can be general method, preferably, the preparation method of aforementioned polyamic acid polymer comprises the following steps Steps: dissolving the mixture of tetracarboxylic dianhydride component (a1) and diamine component (b1) in a solvent, performing polycondensation reaction at a temperature of 0°C to 100°C and reacting for 1 hour to 24 hours, and then performing vacuum distillation on the above reaction solution with an evaporator to obtain a polyamic acid polymer, or pouring the above reaction solution into a large amount of poor solvent to obtain a precipitate, and then drying the above precipitate by a reduced pressure drying method to obtain a polyamide Amino acid polymer.

用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑相同或不同,且用於聚縮合反應中的溶劑並無特別的限制,只要是可溶解反應物與生成物即可。較佳地,溶劑包含但不限於(1)非質子系極性溶劑,例如:N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidinone;NMP)、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二甲基亞碸、γ-丁內酯、四甲基尿素或六甲基磷酸三胺等之非質子系極性溶劑;(2)酚系溶劑,例如:間-甲酚、二甲苯酚、酚或鹵化酚類等之酚系溶劑。基於混合物之使用量為100重量份,用於聚縮合反應中之溶劑的使用量較佳為200重量份至2000重量份,更佳為300重量份至1800重量份。 The solvent used in the polycondensation reaction may be the same as or different from the solvent in the liquid crystal alignment agent described below, and the solvent used in the polycondensation reaction is not particularly limited as long as it can dissolve the reactants and products. Preferably, the solvents include but are not limited to (1) aprotic polar solvents, such as: N-methyl-2-pyrrolidinone (N-methyl-2-pyrrolidinone; NMP), N,N-dimethylacetamide, N,N-dimethylformamide, dimethylsulfoxide, γ-butyrolactone, tetramethyl urea or hexamethylphosphoric triamine, etc.; (2) phenolic solvents, such as m-formaldehyde Phenol-based solvents such as phenol, xylenol, phenol, or halogenated phenols. Based on 100 parts by weight of the mixture, the amount of the solvent used in the polycondensation reaction is preferably 200 to 2000 parts by weight, more preferably 300 to 1800 parts by weight.

特別地,於聚縮合反應中,溶劑可併用適量的貧溶劑,其中貧溶劑不會造成聚醯胺酸聚合物析出。貧溶劑可以單獨一種使用或者混合複數種使用,且其包含但不限於(1)醇類,例如:甲醇、乙醇、異丙醇、環己醇、乙二醇、丙二醇、1,4-丁二醇或三乙二醇等之醇類;(2)酮類,例如:丙酮、甲基乙基酮、甲基異丁基酮、環己酮等之酮類;(3) 酯類,例如:醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯或乙二醇乙基醚醋酸酯等之酯類;(4)醚類,例如:二乙基醚、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚、乙二醇二甲基醚或二乙二醇二甲基醚等之醚類;(5)鹵化烴類,例如:二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯或鄰-二氯苯等之鹵化烴類;(6)烴類,例如:四氫呋喃、己烷、庚烷、辛烷、苯、甲苯或二甲苯等之烴類或上述溶劑之任意組合。基於二胺組份(b1)的使用量為100重量份,貧溶劑的使用量較佳為0重量份至60重量份,更佳為0重量份至50重量份。 In particular, in the polycondensation reaction, the solvent can be combined with an appropriate amount of poor solvent, wherein the poor solvent will not cause the polyamic acid polymer to precipitate. Poor solvents can be used alone or in combination, and include but are not limited to (1) alcohols, such as methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol or triethylene glycol; (2) ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc.; (3) Esters, such as methyl acetate, ethyl acetate, butyl acetate, diethyl oxalate, diethyl malonate or ethylene glycol ethyl ether acetate; (4) ethers, such as diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether, etc.; (5) halogenated hydrocarbons (6) Hydrocarbons, such as tetrahydrofuran, hexane, heptane, octane, benzene, toluene or xylene, or any combination of the above solvents. Based on 100 parts by weight of the diamine component (b1), the used amount of the poor solvent is preferably 0 to 60 parts by weight, more preferably 0 to 50 parts by weight.

本發明之聚醯亞胺聚合物之製備可為一般之方法,較佳地,聚醯亞胺聚合物之製備方法先將混合物溶解於溶液中,其中混合物包含四羧酸二酐組份(a1)與二胺組份(b1),並進行聚合反應,以形成聚醯胺酸聚合物。接著,在脫水劑及觸媒的存在下,進一步加熱,並進行脫水閉環反應,使得聚醯胺酸聚合物中的醯胺酸官能基經由脫水閉環反應轉變成醯亞胺官能基(即醯亞胺化),而得到聚醯亞胺聚合物。 The preparation of the polyimide polymer of the present invention can be a general method. Preferably, the preparation method of the polyimide polymer first dissolves a mixture in a solution, wherein the mixture includes the tetracarboxylic dianhydride component (a1) and the diamine component (b1), and carries out a polymerization reaction to form a polyamic acid polymer. Then, in the presence of a dehydrating agent and a catalyst, further heating, and a dehydration ring-closing reaction is carried out, so that the amide acid functional group in the polyamic acid polymer is converted into an imide functional group through a dehydration ring-closure reaction (i.e., imidization), and a polyimide polymer is obtained.

用於脫水閉環反應中之溶劑可與下述液晶配向劑中的溶劑相同,故不另贅述。基於聚醯胺酸聚合物的使用量為100重量份,用於脫水閉環反應中的溶劑的使用量較佳為200重量份至2000重量份,更佳為300重量份至1800重量份。 The solvent used in the dehydration ring-closing reaction may be the same as the solvent in the liquid crystal alignment agent described below, so it will not be described in detail. Based on 100 parts by weight of the polyamic acid polymer, the amount of the solvent used in the dehydration ring closure reaction is preferably 200 to 2000 parts by weight, more preferably 300 to 1800 parts by weight.

為獲得較佳之聚醯胺酸聚合物的醯亞胺化程度,脫水閉環反應的操作溫度較佳為40℃至200℃,更佳為40℃至150℃。若脫水閉環反應的操作溫度低於40℃時,醯亞胺化之反應不完全,而降低聚醯胺酸聚合物的醯亞胺化程度。然而,若脫水閉環反應的操作溫度高於200℃時,所得的聚醯亞胺聚合物的重量平均分子量偏低。 In order to obtain a better degree of imidization of the polyamic acid polymer, the operating temperature of the dehydration ring closure reaction is preferably from 40°C to 200°C, more preferably from 40°C to 150°C. If the operating temperature of the dehydration ring-closing reaction is lower than 40° C., the imidization reaction will not be complete, and the degree of imidization of the polyamic acid polymer will be reduced. However, if the operating temperature of the dehydration ring-closing reaction is higher than 200° C., the weight average molecular weight of the obtained polyimide polymer is relatively low.

用於脫水閉環反應中的脫水劑可選自於酸酐類化合物,其具體例如:醋酸酐、丙酸酐或三氟醋酸酐等之酸酐類化合物。基於聚醯胺酸聚合物為1莫耳,脫水劑的使用量為0.01莫耳至20莫耳。用於脫水閉環反應中的觸媒可選自於(1)吡啶類化合物,例如:吡啶、三甲基吡啶或二甲基吡啶等之吡啶類化合物;(2)三級胺類化合物,例如:三乙基胺等之三級胺類化合物。基於脫水劑的使用量為1莫耳,觸媒的使用量為0.5莫耳至10莫耳。 The dehydrating agent used in the dehydration ring-closing reaction can be selected from acid anhydride compounds, for example, acid anhydride compounds such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride. Based on 1 mole of the polyamide acid polymer, the amount of the dehydrating agent is 0.01 mole to 20 mole. The catalyst used in the dehydration ring-closing reaction can be selected from (1) pyridine compounds, such as pyridine compounds such as pyridine, collidine or lutidine; (2) tertiary amine compounds, such as triethylamine and other tertiary amine compounds. Based on the usage amount of the dehydrating agent being 1 mole, the usage amount of the catalyst is 0.5 mole to 10 mole.

本發明之聚醯亞胺系嵌段共聚合物之較佳具體例為聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物,或其任意組合。 A preferred specific example of the polyimide-based block copolymer of the present invention is a polyamic acid block copolymer, a polyimide block copolymer, a polyamic acid-polyimide block copolymer, or any combination thereof.

本發明之聚醯亞胺系嵌段共聚合物之製備可為一般之方法,較佳地,聚醯亞胺系嵌段共聚合物之製備方法先將起始物溶解於溶劑中,並進行聚縮合反應,其中所述起始物包含上述之至少一種聚醯胺酸聚合物及/或上述之至少一種聚醯亞胺聚合物,且可進一步地包含四羧酸二酐組份(a1)及二胺組份(b1)。 The preparation of the polyimide-based block copolymer of the present invention can be a general method. Preferably, the preparation method of the polyimide-based block copolymer first dissolves the starting material in a solvent, and carries out polycondensation reaction, wherein the starting material includes the above-mentioned at least one polyamic acid polymer and/or the above-mentioned at least one polyimide polymer, and may further include a tetracarboxylic dianhydride component (a1) and a diamine component (b1).

前述起始物中之四羧酸二酐組份(a1)與二胺組 份(b1)是與上述製備聚醯胺酸聚合物中所使用的四羧酸二酐組份(a1)與二胺組份(b1)相同,且用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑相同,在此不另贅述。 Tetracarboxylic dianhydride component (a1) and diamine group in the aforementioned starting material Part (b1) is the same as the tetracarboxylic dianhydride component (a1) and the diamine component (b1) used in the above-mentioned preparation of the polyamic acid polymer, and the solvent used in the polycondensation reaction can be the same as the solvent in the liquid crystal alignment agent described below, and will not be repeated here.

基於前述起始物的使用量為100重量份,用於聚縮合反應中之溶劑的使用量較佳為200重量份至2000重量份,更佳為300重量份至1800重量份。聚縮合反應的操作溫度較佳為0℃至200℃,且更佳為0℃至100℃。 Based on 100 parts by weight of the aforementioned starting material, the amount of the solvent used in the polycondensation reaction is preferably 200 to 2000 parts by weight, more preferably 300 to 1800 parts by weight. The operating temperature of the polycondensation reaction is preferably from 0°C to 200°C, and more preferably from 0°C to 100°C.

較佳地,起始物包含但不限於(1)二種末端基相異且結構相異之聚醯胺酸聚合物;(2)二種末端基相異且結構相異之聚醯亞胺聚合物;(3)末端基相異且結構相異之聚醯胺酸聚合物及聚醯亞胺聚合物;(4)聚醯胺酸聚合物、四羧酸二酐化合物及二胺化合物,其中,四羧酸二酐化合物及二胺化合物之中的至少一種與形成聚醯胺酸聚合物所使用的四羧酸二酐組份(a1)及二胺組份(b1)的結構相異;(5)聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物,其中,所述四羧酸二酐化合物及二胺化合物中的至少一種與形成聚醯亞胺聚合物所使用的四羧酸二酐組份(a1)及二胺組份(b1)的結構相異;(6)聚醯胺酸聚合物、聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物,其中,四羧酸二酐化合物及二胺中的至少一種與形成聚醯胺酸聚合物或聚醯亞胺聚合物所使用的四羧酸二酐組份(a1)及二胺組份(b1)的結構相異;(7)二種結構相異之聚醯胺酸聚合物、四羧酸二酐化合物及二胺化合物;(8)二種結構相異之聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物;(9)二種末端基為酸酐基 且結構相異的聚醯胺酸聚合物以及二胺化合物;(10)二種末端基為胺基且結構相異的聚醯胺酸聚合物以及四羧酸二酐化合物;(11)二種末端基為酸酐基且結構相異的聚醯亞胺聚合物以及二胺化合物;(12)二種末端基為胺基且結構相異的聚醯亞胺聚合物以及四羧酸二酐化合物。 Preferably, the starting materials include but are not limited to (1) two polyamic acid polymers with different terminal groups and different structures; (2) two polyimide polymers with different terminal groups and different structures; (3) polyamic acid polymers and polyimide polymers with different terminal groups and different structures; The structures of the tetracarboxylic dianhydride component (a1) and the diamine component (b1) used to form the polyamic acid polymer are different; (5) the polyimide polymer, the tetracarboxylic dianhydride compound and the diamine compound, wherein, at least one of the tetracarboxylic dianhydride compound and the diamine compound is different from the structure of the tetracarboxylic dianhydride component (a1) and the diamine component (b1) used to form the polyimide polymer; (6) the polyimide polymer, Polyimide polymer, tetracarboxylic dianhydride compound and diamine compound, wherein, at least one of tetracarboxylic dianhydride compound and diamine is different from the structure of tetracarboxylic dianhydride component (a1) and diamine component (b1) used to form polyamic acid polymer or polyimide polymer; (7) two kinds of polyamic acid polymers with different structures, tetracarboxylic dianhydride compounds and diamine compounds; (8) two kinds of polyimide polymers with different structures , Tetracarboxylic dianhydride compounds and diamine compounds; (9) The two terminal groups are acid anhydride groups (10) Two kinds of polyamic acid polymers and tetracarboxylic dianhydride compounds whose end groups are amine groups and have different structures; (11) Two kinds of polyimide polymers and diamine compounds whose end groups are anhydride groups and have different structures; (12) Two kinds of polyimide polymers and tetracarboxylic dianhydride compounds whose end groups are amine groups and have different structures.

在不影響本發明之功效範圍內,較佳地,前述聚醯胺酸聚合物、前述聚醯亞胺聚合物以及前述聚醯亞胺系嵌段共聚合物可以是先進行分子量調節後的末端修飾型聚合物。藉由使用末端修飾型的聚合物,可改善液晶配向劑的塗佈性能。製備前述末端修飾型聚合物的方式可藉由在聚醯胺酸聚合物進行聚縮合反應的同時,加入單官能性化合物來製得,單官能性化合物包含但不限於(1)一元酸酐,例如:馬來酸酐、鄰苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基琥珀酸酐或正十六烷基琥珀酸酐等之一元酸酐;(2)單胺化合物,例如:苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷胺、正十八烷胺或正二十烷胺等之單胺化合物;(3)單異氰酸酯化合物,例如:異氰酸苯酯或異氰酸萘基酯等之單異氰酸酯化合物。 Within the scope of not affecting the efficacy of the present invention, preferably, the aforementioned polyamic acid polymer, the aforementioned polyimide polymer and the aforementioned polyimide-based block copolymer may be end-modified polymers that are first adjusted in molecular weight. By using terminal-modified polymers, the coating performance of the liquid crystal alignment agent can be improved. The method of preparing the above-mentioned end-modified polymer can be obtained by adding a monofunctional compound while the polyamic acid polymer undergoes a polycondensation reaction. The monofunctional compound includes but is not limited to (1) monobasic anhydrides, such as: maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride or n-hexadecyl succinic anhydride; (2) monoamine compounds, such as: aniline , cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine, n-decylamine, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, n-octadecylamine or n-eicosylamine;

本發明的第一聚合物(A1)根據凝膠滲透色層分析法所測得經聚苯乙烯換算的重量平均分子量為10,000至90,000,較佳為12,000至75,000,且更佳為15,000至60,000。 The first polymer (A1) of the present invention has a polystyrene-equivalent weight average molecular weight of 10,000 to 90,000, preferably 12,000 to 75,000, and more preferably 15,000 to 60,000 as measured by gel permeation chromatography.

第二聚合物(A2)Second polymer (A2)

本發明之聚合物(A)可進一步包含第二聚合物(A2),且第二聚合物(A2)係由四羧酸二酐組份(a2)與二胺組份(b2)反應而製得。 The polymer (A) of the present invention may further comprise a second polymer (A2), and the second polymer (A2) is prepared by reacting a tetracarboxylic dianhydride component (a2) with a diamine component (b2).

上述聚合物(A2)之較佳具體例為聚醯胺酸聚合物、聚醯亞胺聚合物、聚醯亞胺系嵌段共聚合物或其組合。其中,聚醯亞胺系嵌段共聚合物之較佳具體例為聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物或其任意組合。 Preferred specific examples of the above-mentioned polymer (A2) are polyamic acid polymers, polyimide polymers, polyimide-based block copolymers, or combinations thereof. Among them, preferred specific examples of polyimide-based block copolymers are polyamic acid block copolymers, polyimide block copolymers, polyamic acid-polyimide block copolymers, or any combination thereof.

四羧酸二酐組份(a2)Tetracarboxylic dianhydride component (a2)

前述四羧酸二酐組份(a2)之具體例可包含(1)脂肪族四羧酸二酐化合物、(2)脂環族四羧酸二酐化合物、(3)芳香族四羧酸二酐化合物或(4)具有前述式(1-1)至式(1-6)所示之結構的四羧酸二酐化合物等。此些四羧酸二酐化合物係相同於前述之其他四羧酸二酐化合物(a1-2),故在此不另贅述。 Specific examples of the aforementioned tetracarboxylic dianhydride component (a2) may include (1) aliphatic tetracarboxylic dianhydride compounds, (2) alicyclic tetracarboxylic dianhydride compounds, (3) aromatic tetracarboxylic dianhydride compounds or (4) tetracarboxylic dianhydride compounds having the structures shown in the aforementioned formula (1-1) to formula (1-6). These tetracarboxylic dianhydride compounds are the same as the aforementioned other tetracarboxylic dianhydride compounds (a1-2), so they will not be repeated here.

前述四羧酸二酐組份(a2)可以單獨一種使用或者混合複數種使用。 The aforementioned tetracarboxylic dianhydride component (a2) may be used alone or in combination of plural kinds.

二胺組份(b2)Diamine component (b2)

二胺化合物(b2-1)Diamine compound (b2-1)

本發明之二胺組份(b2)可包含至少一種二胺化合物(b2-1),其具有如下式(III)所示之結構: The diamine component (b2) of the present invention may comprise at least one diamine compound (b2-1), which has a structure shown in the following formula (III):

Figure 108143269-A0101-12-0033-115
Figure 108143269-A0101-12-0033-115

於式(III)中,W1各自獨立地代表氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基或乙醯胺基、氟原子、氯原子或溴原子;W2各自獨立地代表碳數為1至3的烷基;m1各自獨立地代表0至3的整數;且m2代表0至4的整數。 In formula (III), W 1 each independently represents a hydrogen atom, an alkyl group with a carbon number of 1 to 10, an alkoxy group or acetamido group with a carbon number of 1 to 10, a fluorine atom, a chlorine atom or a bromine atom; W 2 each independently represent an alkyl group with a carbon number of 1 to 3; each m1 independently represents an integer of 0 to 3; and m2 represents an integer of 0 to 4.

於式(III)中,W1較佳可各自獨立地代表氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基或乙醯胺基。當W1各自獨立地代表氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基或乙醯胺基時,所製得之液晶顯示元件具有更佳之電荷消除耐光性。 In formula (III), W 1 preferably each independently represent a hydrogen atom, an alkyl group with 1 to 10 carbons, an alkoxy group with 1 to 10 carbons, or an acetamide group. When W 1 each independently represents a hydrogen atom, an alkyl group with a carbon number of 1 to 10, an alkoxy group with a carbon number of 1 to 10, or an acetamide group, the resulting liquid crystal display device has better charge elimination and light resistance.

如式(III)所示之二胺化合物(b2-1)的具體例可包含但不限如下式(III-1)至式(III-28)所示之二胺化合物: Specific examples of the diamine compound (b2-1) shown in formula (III) may include but not limited to diamine compounds shown in the following formula (III-1) to formula (III-28):

Figure 108143269-A0101-12-0034-116
Figure 108143269-A0101-12-0034-116

Figure 108143269-A0101-12-0034-117
Figure 108143269-A0101-12-0034-117

Figure 108143269-A0101-12-0034-118
Figure 108143269-A0101-12-0034-118

Figure 108143269-A0101-12-0034-119
Figure 108143269-A0101-12-0034-119

Figure 108143269-A0101-12-0034-120
Figure 108143269-A0101-12-0034-120

Figure 108143269-A0101-12-0035-122
Figure 108143269-A0101-12-0035-122

Figure 108143269-A0101-12-0035-123
Figure 108143269-A0101-12-0035-123

Figure 108143269-A0101-12-0035-124
Figure 108143269-A0101-12-0035-124

Figure 108143269-A0101-12-0035-125
Figure 108143269-A0101-12-0035-125

Figure 108143269-A0101-12-0035-126
Figure 108143269-A0101-12-0035-126

Figure 108143269-A0101-12-0035-127
Figure 108143269-A0101-12-0035-127

Figure 108143269-A0101-12-0035-128
Figure 108143269-A0101-12-0035-128

Figure 108143269-A0101-12-0035-121
Figure 108143269-A0101-12-0035-121

Figure 108143269-A0101-12-0036-129
Figure 108143269-A0101-12-0036-129

Figure 108143269-A0101-12-0036-130
Figure 108143269-A0101-12-0036-130

Figure 108143269-A0101-12-0036-131
Figure 108143269-A0101-12-0036-131

Figure 108143269-A0101-12-0036-132
Figure 108143269-A0101-12-0036-132

Figure 108143269-A0101-12-0036-133
Figure 108143269-A0101-12-0036-133

Figure 108143269-A0101-12-0036-134
Figure 108143269-A0101-12-0036-134

Figure 108143269-A0101-12-0036-135
Figure 108143269-A0101-12-0036-135

Figure 108143269-A0101-12-0037-137
Figure 108143269-A0101-12-0037-137

Figure 108143269-A0101-12-0037-138
Figure 108143269-A0101-12-0037-138

Figure 108143269-A0101-12-0037-139
Figure 108143269-A0101-12-0037-139

Figure 108143269-A0101-12-0037-140
Figure 108143269-A0101-12-0037-140

Figure 108143269-A0101-12-0037-141
Figure 108143269-A0101-12-0037-141

Figure 108143269-A0101-12-0037-142
Figure 108143269-A0101-12-0037-142

Figure 108143269-A0101-12-0037-136
Figure 108143269-A0101-12-0037-136

Figure 108143269-A0101-12-0038-143
Figure 108143269-A0101-12-0038-143

前述之二胺化合物(b2-1)可單獨一種使用或混合複數種使用。 The above-mentioned diamine compound (b2-1) can be used individually by 1 type or in mixture of several types.

基於二胺組份(b2)之總使用量為100莫耳,二胺化合物(b2-1)之使用量為5莫耳至75莫耳,較佳為5莫耳至60莫耳,且更佳為5莫耳至50莫耳。 Based on the total usage amount of diamine component (b2) being 100 mol, the usage amount of diamine compound (b2-1) is 5 mol to 75 mol, preferably 5 mol to 60 mol, and more preferably 5 mol to 50 mol.

此外,若二胺組份(b2)包含二胺化合物(b2-1)時,可進一步提升所形成的液晶顯示元件的電荷消除耐光性。 In addition, if the diamine component (b2) contains the diamine compound (b2-1), the charge-eliminating light resistance of the formed liquid crystal display device can be further improved.

含羧酸基之二胺化合物(b2-2)Diamine compound containing carboxylic acid group (b2-2)

本發明之二胺組份(b2)可進一步包含含羧酸基之二胺化合物(b2-2),且其具有下式(IV)所示之結構: The diamine component (b2) of the present invention may further include a carboxylic acid group-containing diamine compound (b2-2), which has a structure represented by the following formula (IV):

Figure 108143269-A0101-12-0038-144
Figure 108143269-A0101-12-0038-144

於式(IV)中,Y代表含碳數為6至30的芳香環之有機基團,且n代表1至4的整數。 In formula (IV), Y represents an organic group containing an aromatic ring having 6 to 30 carbons, and n represents an integer of 1 to 4.

上述含羧酸基之二胺化合物(b2-2)只要具有羧酸基即可,其結構並沒有特別限定,且前述含羧酸基之二胺化合物(b2-2)可包含但不限於脂肪族二胺、脂環族二胺、芳香族二胺或二胺基有機矽氧烷。前述含羧酸基之二胺化合物(b2-2)較佳可為脂環族二胺或芳香族二胺,更佳可為芳香族 二胺。 The above-mentioned carboxylic acid group-containing diamine compound (b2-2) is not particularly limited as long as it has a carboxylic acid group, and the above-mentioned carboxylic acid group-containing diamine compound (b2-2) may include but not limited to aliphatic diamine, alicyclic diamine, aromatic diamine or diaminoorganosiloxane. The above-mentioned diamine compound (b2-2) containing carboxylic acid groups is preferably an alicyclic diamine or an aromatic diamine, more preferably an aromatic diamine.

前述含羧酸基之二胺化合物(b2-2)可具有1至4個羧酸基,較佳可具有1或2個羧酸基。 The aforementioned carboxylic acid group-containing diamine compound (b2-2) may have 1 to 4 carboxylic acid groups, preferably may have 1 or 2 carboxylic acid groups.

前述含羧酸基之二胺化合物(b2-2)為選自於由下式(IV-1)至式(IV-5)所組成之族群之至少一者: The aforementioned carboxylic acid group-containing diamine compound (b2-2) is at least one selected from the group consisting of the following formula (IV-1) to formula (IV-5):

Figure 108143269-A0101-12-0039-145
Figure 108143269-A0101-12-0039-145

Figure 108143269-A0101-12-0039-146
Figure 108143269-A0101-12-0039-146

Figure 108143269-A0101-12-0039-147
Figure 108143269-A0101-12-0039-147

Figure 108143269-A0101-12-0039-148
Figure 108143269-A0101-12-0039-148

Figure 108143269-A0101-12-0039-149
Figure 108143269-A0101-12-0039-149

在式(IV-1)至式(IV-5)中,Y1及Y3各自獨立地代表單鍵、-CH2-、-C2H4-、-C(CH3)2-、-CF2-、-C(CF3)2-、-O-、 -CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-;Y2代表碳數為1至5的直鏈烷基或碳數為1至5的支鏈烷基;n1及n7各自獨立地代表1至4的整數;n2及n3各自獨立地代表0至4的整數,n2與n3之總和為1至4的整數;且n4、n5及n6各自獨立地代表1至5的整數。 In formula (IV-1) to formula (IV-5), Y1and Y3Each independently represents a single bond, -CH2-, -C2h4-, -C(CH3)2-, -CF2-, -C(CF3)2-, -O-, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -CH2O-, -OCH2-, -COO-, -OCO-, -CON(CH3)-or-N(CH3) CO-; Y2Represents a straight-chain alkyl group with a carbon number of 1 to 5 or a branched chain alkyl group with a carbon number of 1 to 5; n1 and n7 each independently represent an integer from 1 to 4; n2 and n3 each independently represent an integer from 0 to 4, and the sum of n2 and n3 is an integer from 1 to 4; and n4, n5 and n6 each independently represent an integer from 1 to 5.

較佳地,於式(IV-1)中,n1可代表1或2的整數;於式(IV-2)中,Y1代表單鍵、-CH2-、-C2H4-、-C(CH3)2-、-O-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-或-OCO-,且n2及n3同時為1;於式(IV-5)中,Y3代表單鍵、-CH2-、-O-、-CO-、-NH-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-或-OCO-,且n7代表1或2的整數。 Preferably, in formula (IV-1), n1 can represent an integer of 1 or 2; in formula (IV-2), Y1 represents a single bond, -CH2- , -C2H4-, -C(CH3)2-, -O-, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -COO- or -OCO-, and n2 and n3 are 1 at the same time; In formula (IV-5), Y 3 represents a single bond, -CH 2 - , -O- , -CO- , -NH-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 - , -COO- or -OCO-, and n7 represents an integer of 1 or 2.

前述含羧酸基之二胺化合物(b2-2)之具體例可包含但不限如下式(IV-6)至式(IV-16)所示之二胺化合物: Specific examples of the aforementioned carboxylic acid group-containing diamine compound (b2-2) may include, but are not limited to, the diamine compounds shown in the following formula (IV-6) to formula (IV-16):

Figure 108143269-A0101-12-0040-150
Figure 108143269-A0101-12-0040-150

Figure 108143269-A0101-12-0041-151
Figure 108143269-A0101-12-0041-151

於前述式(IV-14)及式(IV-15)中,A可代表單鍵、-CH2-、-O-、-CO-、-NH-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-或-OCO-。 In the aforementioned formula (IV-14) and formula (IV-15), A may represent a single bond, -CH 2 -, -O-, -CO-, -NH-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 -, -COO- or -OCO-.

當含羧酸基之二胺化合物((b2-2)為前述式(IV-1)至式(IV-5)所示之至少一者時,所形成之液晶顯示元件可具有較佳之電荷消除耐光性。 When the carboxylic acid group-containing diamine compound ((b2-2) is at least one of the aforementioned formula (IV-1) to formula (IV-5), the formed liquid crystal display device can have better charge elimination and light resistance.

前述含羧酸基之二胺化合物(b2-2)可單獨一種使用或混合複數種使用。 The said carboxylic acid group containing diamine compound (b2-2) can be used individually by 1 type or in mixture of several types.

基於二胺組份(b2)的總使用量為100莫耳,含羧酸基之二胺化合物(b2-2)的使用量為25莫耳至95莫耳,較佳為40莫耳至95莫耳,且更佳為50莫耳至95莫耳。 Based on the total usage amount of the diamine component (b2) being 100 moles, the usage amount of the diamine compound (b2-2) containing carboxylic acid group is 25 moles to 95 moles, preferably 40 moles to 95 moles, and more preferably 50 moles to 95 moles.

此外,若二胺組份(b2)包含二胺化合物(b2-2)時,可進一步提升所形成的液晶顯示元件的電荷消除耐光性。 In addition, if the diamine component (b2) contains the diamine compound (b2-2), the charge-eliminating light resistance of the formed liquid crystal display device can be further improved.

其他二胺化合物(b2-3)Other diamine compounds (b2-3)

本發明之二胺組份(b2)可進一步包含其他二胺化合物(b2-3)。 The diamine component (b2) of the present invention may further contain other diamine compounds (b2-3).

其他二胺化合物(b2-3)相同於前述之其他二胺化合物(b1-2),故在此不另贅述。 The other diamine compounds (b2-3) are the same as the above-mentioned other diamine compounds (b1-2), so they will not be repeated here.

第二聚合物(A2)的製備方法The preparation method of the second polymer (A2)

本發明之第二聚合物(A2)之製備方法與前述第一聚合物(A1)之製備方法相同,不同之處是第二聚合物(A2)係使用前述之四羧酸二酐組份(a2)與二胺組份(b2)來反應製得,故在此不另贅述第二聚合物(A2)的製備方法。 The preparation method of the second polymer (A2) of the present invention is the same as the preparation method of the aforementioned first polymer (A1), except that the second polymer (A2) is prepared by reacting the aforementioned tetracarboxylic dianhydride component (a2) and diamine component (b2), so the preparation method of the second polymer (A2) will not be repeated here.

基於聚合物(A)之總使用量為100重量份,第一聚合物(A1)之使用量為10重量份至90重量份,且第二聚合物(A2)之使用量為90重量份至10重量份。 Based on the total amount of the polymer (A) being 100 parts by weight, the amount of the first polymer (A1) is 10 to 90 parts by weight, and the amount of the second polymer (A2) is 90 to 10 parts by weight.

當第一聚合物(A1)之使用量及第二聚合物(A2)之使用量為前述之範圍時,則可進一步提升所形成的液晶顯示元件的電荷消除耐光性。 When the usage-amount of the first polymer (A1) and the usage-amount of the second polymer (A2) are in the aforementioned range, the charge-eliminating light resistance of the formed liquid crystal display element can be further improved.

溶劑(B)solvent (B)

本發明的液晶配向劑中所使用的溶劑並無特別的限制,只要是可溶解聚合物(A)與其他任意成份,且不與其產生反應即可,較佳為同前述合成聚醯胺酸中所使用的溶劑,同時,亦可併用合成前述聚醯胺酸時所使用的貧溶劑。 The solvent used in the liquid crystal alignment agent of the present invention is not particularly limited, as long as it can dissolve the polymer (A) and any other components without reacting with it.

溶劑(B)的具體例包含但不限於N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidone,NMP)、γ-丁內酯、γ-丁內醯胺、4-羥基-4-甲基-2-戊酮、乙二醇單甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚(ethylene glycol n-butyl ether)、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二乙二醇二甲基醚、二乙二醇二乙基醚、二乙二醇單甲基醚、二乙二醇單乙基醚、二乙二醇單甲基醚乙酸酯、二乙二醇單乙基醚乙酸酯或N,N-二甲基甲醯胺或N,N-二甲基乙醯胺(N,N-dimethyl acetamide)等。 Specific examples of solvent (B) include but are not limited to N-methyl-2-pyrrolidone (N-methyl-2-pyrrolidone, NMP), γ-butyrolactone, γ-butyrolactam, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxy propionate, ethyl ethoxy propionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethyl Glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate or N,N-dimethylformamide or N,N-dimethylethyl ether Amide (N,N-dimethyl acetamide), etc.

溶劑(B)可以單獨一種使用或者混合複數種使用。 A solvent (B) can be used individually by 1 type or in mixture of several types.

基於聚合物(A)的使用量為100重量份,溶劑(B)的使用量為800重量份至4000重量份,較佳為900重量份至3500重量份,且更佳為1000至3000重量份。 Based on the polymer (A) used in an amount of 100 parts by weight, the solvent (B) used in an amount of 800 to 4000 parts by weight, preferably 900 to 3500 parts by weight, and more preferably 1000 to 3000 parts by weight.

添加劑(C)Additive (C)

在不影響本發明之功效範圍內,本發明之液晶配向劑可選擇性地包含添加劑(C),且添加劑(C)可為環氧 化合物或具有官能性基團之矽烷化合物等。添加劑(C)的作用是用來提高前述液晶配向膜與基板表面的附著性。添加劑(C)可以單獨一種使用或者混合複數種使用。 Within the scope of not affecting the efficacy of the present invention, the liquid crystal alignment agent of the present invention may optionally contain additive (C), and additive (C) may be epoxy Compounds or silane compounds with functional groups, etc. The function of the additive (C) is to improve the adhesion between the aforementioned liquid crystal alignment film and the surface of the substrate. Additives (C) may be used alone or in combination.

前述之環氧化合物可包含但不限於乙二醇二環氧丙基醚、聚乙二醇二環氧丙基醚、丙二醇二環氧丙基醚、三丙二醇二環氧丙基醚、聚丙二醇二環氧丙基醚、新戊二醇二環氧丙基醚、1,6-己二醇二環氧丙基醚、丙三醇二環氧丙基醚、2,2-二溴新戊二醇二環氧丙基醚、1,3,5,6-四環氧丙基-2,4-己二醇、N,N,N',N'-四環氧丙基-間-二甲苯二胺、1,3-雙(N,N-二環氧丙基胺基甲基)環己烷、N,N,N',N'-四環氧丙基-4,4'-二胺基二苯基甲烷、N,N-環氧丙基-對-環氧丙氧基苯胺、3-(N-烯丙基-N-環氧丙基)胺基丙基三甲氧基矽烷、3-(N,N-二環氧丙基)胺基丙基三甲氧基矽烷等。 The aforementioned epoxy compounds may include but not limited to ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4 -hexanediol, N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diecidylaminomethyl)cyclohexane, N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane, N,N-epoxypropyl-p-glycidoxyaniline, 3-(N-allyl-N-epoxypropyl)aminopropyltrimethoxysilane, 3-(N , N-diepoxypropyl) aminopropyl trimethoxysilane and so on.

基於聚合物(A)的使用量為100重量份,環氧化合物的使用量一般為40重量份以下,且較佳為0.1重量份至30重量份。 Based on 100 parts by weight of the polymer (A), the usage of the epoxy compound is generally less than 40 parts by weight, and preferably 0.1 to 30 parts by weight.

上述具有官能性基團之矽烷化合物可包含但不限於3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷(3-ureidopropyltrimethoxysilane)、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基 丙基三伸乙三胺、N-三甲氧基矽烷基丙基三伸乙三胺、10-三甲氧基矽烷基-1,4,7-三吖癸烷、10-三乙氧基矽烷基-1,4,7-三吖癸烷、9-三甲氧基矽烷基-3,6-二吖壬基醋酸酯、9-三乙氧基矽烷基-3,6-二吖壬基醋酸酯、N-苯甲基-3-胺基丙基三甲氧基矽烷、N-苯甲基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三甲氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷等。 The above-mentioned silane compounds with functional groups may include but not limited to 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane Alkane (3-ureidopropyltrimethoxysilane), 3-ureidopropyltriethoxysilane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilane Propyltriethylenetriamine, N-trimethoxysilylpropyltriethylenetriamine, 10-trimethoxysilyl-1,4,7-triazidecane, 10-triethoxysilyl-1,4,7-triazidecane, 9-trimethoxysilyl-3,6-diazinonyl acetate, 9-triethoxysilyl-3,6-diazinonyl acetate, N-benzyl-3-aminopropyltrimethoxysilane, N-phenyl Methyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, N-bis(oxyethylene)-3-aminopropyltrimethoxysilane, N-bis(oxyethylene)-3-aminopropyltriethoxysilane, etc.

基於聚合物(A)的使用量為100重量份,矽烷化合物的使用量一般為10重量份以下,且較佳為0.5重量份至10重量份。 Based on 100 parts by weight of the polymer (A), the used amount of the silane compound is generally less than 10 parts by weight, and preferably 0.5 to 10 parts by weight.

基於聚合物(A)的使用量為100重量份,添加劑(C)的使用量可為0.5重量份至50重量份,且較佳為1重量份至45重量份。 Based on 100 parts by weight of the polymer (A), the additive (C) may be used in an amount of 0.5 to 50 parts by weight, and preferably 1 to 45 parts by weight.

液晶配向劑的製備方法Preparation method of liquid crystal alignment agent

本發明之液晶配向劑之製備方法並無特別之限制,可採用一般之混合方法,如先將四羧酸二酐組份(a1)及二胺組份(b1)混合均勻,以反應形成含有第一聚合物(A1)之聚合物(A)。接著,將聚合物(A)於溫度為0℃至200℃的條件下加入溶劑(B)和添加劑(C),以攪拌裝置持續攪拌至溶解即可。較佳地,於20℃至60℃的溫度下,將聚合物(A)和添加劑(C)加入溶劑(B)。此外,聚合物(A)亦可選擇性地含有利用四羧酸二酐組份(a2)及二胺組份(b2)反應製得之第二聚合物(A2)。 The preparation method of the liquid crystal alignment agent of the present invention is not particularly limited, and a general mixing method can be used, such as first mixing the tetracarboxylic dianhydride component (a1) and the diamine component (b1) uniformly to react to form the polymer (A) containing the first polymer (A1). Next, add the solvent (B) and the additive (C) to the polymer (A) at a temperature of 0° C. to 200° C., and continue stirring with a stirring device until it dissolves. Preferably, the polymer (A) and the additive (C) are added to the solvent (B) at a temperature of 20°C to 60°C. In addition, the polymer (A) may also optionally contain a second polymer (A2) prepared by reacting the tetracarboxylic dianhydride component (a2) and the diamine component (b2).

液晶配向膜的形成方法Method for forming liquid crystal alignment film

本發明之液晶配向膜是將上述所形成的液晶配向劑塗佈於基板上,並經乾燥和烘烤而製得的膜。 The liquid crystal alignment film of the present invention is a film prepared by coating the liquid crystal alignment agent formed above on a substrate, drying and baking.

本發明之液晶配向劑所塗佈的基板選自於透明材料,其中,透明材料包含但不限於用於液晶顯示裝置的無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃、聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸、聚碳酸酯等,較佳可使用液晶驅動用的ITO電極已形成於基板上者,以簡化製程。再者,對只有單側基板的反射型液晶顯示器而言,前述基板可使用矽晶圓等不透明的材質,在這種情況下的電極可使用鋁等會反射光的材料來形成。本發明之液晶配向劑的塗佈方法可例如旋轉塗佈法、印刷法、噴墨法等。 The substrate coated with the liquid crystal alignment agent of the present invention is selected from transparent materials, wherein the transparent materials include but are not limited to alkali-free glass, soda-lime glass, hard glass (Pileus glass), quartz glass, polyethylene terephthalate, polybutylene terephthalate, polyether phthalate, polycarbonate, etc. used in liquid crystal display devices. It is preferable to use ITO electrodes for liquid crystal driving that have been formed on the substrate to simplify the process. Furthermore, for a reflective liquid crystal display with only one side substrate, the aforementioned substrate can be made of opaque materials such as silicon wafers, and the electrodes in this case can be formed of light-reflecting materials such as aluminum. The coating method of the liquid crystal alignment agent of the present invention can be, for example, spin coating method, printing method, inkjet method and the like.

本發明的液晶配向劑可選擇任意的溫度和時間,進行塗佈後的乾燥和烘烤製程。一般而言,為充分去除所含的有機溶劑,需在50℃至120℃下進行1分鐘至10分鐘的乾燥。之後,在150℃至300℃下進行5分鐘至120分鐘的烘烤。烘烤後的塗膜厚度並未有特別限制,但過薄的塗膜會造成液晶顯示器的可信賴度劣化,故上述塗膜厚度以5nm至300nm為宜,又以10nm至200nm為較佳。 The liquid crystal alignment agent of the present invention can choose any temperature and time, and carry out the drying and baking process after coating. Generally speaking, in order to fully remove the contained organic solvent, it needs to be dried at 50° C. to 120° C. for 1 minute to 10 minutes. After that, baking is performed at 150° C. to 300° C. for 5 minutes to 120 minutes. The thickness of the coating film after baking is not particularly limited, but a coating film that is too thin will deteriorate the reliability of the liquid crystal display. Therefore, the thickness of the coating film is preferably 5nm to 300nm, and more preferably 10nm to 200nm.

本發明之液晶配向劑雖然可進行習知的摩擦定向處理,但在使用光配向處理法的情況時效果更佳。 Although the liquid crystal alignment agent of the present invention can be subjected to conventional rubbing alignment treatment, the effect is better when photo-alignment treatment is used.

光配向處理法的具體例可例如:將前述塗膜的表面,以朝特定方向偏光的放射線照射,然後視情況在150℃至250℃的溫度下進行加熱處理,以賦予上述塗膜液 晶配向能。其中,可使用具有100nm至800nm之波長的紫外線或可見光做為上述放射線,又以波長為100nm至400nm的紫外線較佳,而以波長為200nm至400nm者為更佳。再者,為了改善液晶配向性,可在50℃至250℃下加熱塗膜基板的同時,以放射線照射塗膜基板。前述放射線的照射量較佳為1mJ/cm2至10,000mJ/cm2,又以100mJ/cm2至5,000mJ/cm2為更佳。按照上述方式製得的液晶配向膜,可使液晶分子以一定方向穩定地被配向。 A specific example of the photo-alignment treatment method may be, for example: irradiating the surface of the aforementioned coating film with radiation polarized in a specific direction, and then performing heat treatment at a temperature of 150° C. to 250° C. to impart liquid crystal alignment to the aforementioned coating film. Among them, ultraviolet rays or visible light with a wavelength of 100nm to 800nm can be used as the radiation, and ultraviolet rays with a wavelength of 100nm to 400nm are preferred, and those with a wavelength of 200nm to 400nm are more preferable. Furthermore, in order to improve liquid crystal alignment, the coated substrate may be irradiated with radiation while heating the coated substrate at 50° C. to 250° C. The exposure dose of the aforementioned radiation is preferably 1 mJ/cm 2 to 10,000 mJ/cm 2 , more preferably 100 mJ/cm 2 to 5,000 mJ/cm 2 . The liquid crystal alignment film prepared in the above manner can stably align the liquid crystal molecules in a certain direction.

本發明的液晶配向劑經預烤處理、後烤處理及光配向處理後而形成液晶配向膜,前述液晶配向膜之預傾角為0°至3°。 The liquid crystal alignment agent of the present invention forms a liquid crystal alignment film after pre-bake treatment, post-bake treatment and photo-alignment treatment, and the pre-tilt angle of the liquid crystal alignment film is 0° to 3°.

液晶顯示元件的製造方法Manufacturing method of liquid crystal display element

本發明又提供一種液晶顯示元件,其包含前述之液晶配向膜。 The present invention further provides a liquid crystal display element, which comprises the aforementioned liquid crystal alignment film.

液晶顯示元件之製作方式為本技術領域者所周知,因此,以下僅簡單地進行陳述。 The fabrication methods of liquid crystal display elements are well known to those skilled in the art, therefore, only a brief description is given below.

參閱圖1,本發明液晶顯示元件100之較佳實施例包含第一單元110、第二單元120及液晶單元130,其中第二單元120與第一單元110間隔相對,且液晶單元130設置在第一單元110與第二單元120之間。 1, a preferred embodiment of the liquid crystal display element 100 of the present invention includes a first unit 110, a second unit 120 and a liquid crystal unit 130, wherein the second unit 120 is spaced opposite to the first unit 110, and the liquid crystal unit 130 is arranged between the first unit 110 and the second unit 120.

第一單元110包含第一基板112、電極114及第一液晶配向膜116,其中電極114以櫛齒型圖案化的方式形成於第一基板112之表面,且第一液晶配向膜116形成在電極114之表面。 The first unit 110 includes a first substrate 112, an electrode 114 and a first liquid crystal alignment film 116, wherein the electrode 114 is formed on the surface of the first substrate 112 in a comb-shaped pattern, and the first liquid crystal alignment film 116 is formed on the surface of the electrode 114.

第二單元120包含第二基板122及第二液晶配向膜126,其中第二液晶配向膜126形成在第二基板122的表面。 The second unit 120 includes a second substrate 122 and a second liquid crystal alignment film 126 , wherein the second liquid crystal alignment film 126 is formed on the surface of the second substrate 122 .

第一基板112與第二基板122是選自於透明材料等,其中,透明材料包含但不限於用於液晶顯示裝置的無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃、聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸、聚碳酸酯等。電極114的材質是擇自於氧化錫(SnO2)、氧化銦-氧化錫(In2O3-SnO2)等的透明電極;或鉻等金屬電極。 The first substrate 112 and the second substrate 122 are selected from transparent materials and the like, wherein the transparent materials include but are not limited to alkali-free glass, soda lime glass, hard glass (Pileus glass), quartz glass, polyethylene terephthalate, polybutylene terephthalate, polyether sulfate, polycarbonate, etc. used in liquid crystal display devices. The material of the electrode 114 is selected from transparent electrodes such as tin oxide (SnO 2 ), indium oxide-tin oxide (In 2 O 3 —SnO 2 ), or metal electrodes such as chromium.

第一液晶配向膜116及第二液晶配向膜126分別為上述之液晶配向膜,其作用在於使液晶單元130形成預傾角,且液晶單元130可被電極114產生的平行電場驅動。 The first liquid crystal alignment film 116 and the second liquid crystal alignment film 126 are the above-mentioned liquid crystal alignment films respectively, and their function is to make the liquid crystal unit 130 form a pretilt angle, and the liquid crystal unit 130 can be driven by the parallel electric field generated by the electrode 114 .

液晶單元130所使用的液晶可單獨或混合複數種使用,液晶包含但不限於二胺基苯類液晶、噠嗪(pyridazine)類液晶、希夫氏鹼(shiff base)類液晶、氧化偶氮基(azoxy)類液晶、聯苯類液晶、苯基環己烷類液晶、聯苯(biphenyl)類液晶、苯基環己烷(phenylcyclohexane)類液晶、酯(ester)類液晶、三聯苯(terphenyl)、聯苯環己烷(biphenylcyclohexane)類液晶、嘧啶(pyrimidine)類液晶、二氧六環(dioxane)類液晶、雙環辛烷(bicyclooctane)類液晶、立方烷(cubane)類液晶等,且可視需求再添加如氯化膽固醇(cholesteryl chloride)、膽固醇壬酸酯(cholesteryl nonanoate)、膽固醇碳酸酯(cholesteryl carbonate)等的膽固醇型液晶,或是以商品名為「C-15」、 「CB-15」(默克公司製造)的對掌(chiral)劑等,或者對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸酯等強誘電性(ferroelectric)類液晶。 The liquid crystals used in the liquid crystal unit 130 can be used alone or in combination. The liquid crystals include but are not limited to diaminobenzene liquid crystals, pyridazine liquid crystals, Schiff base liquid crystals, azoxy liquid crystals, biphenyl liquid crystals, phenylcyclohexane liquid crystals, biphenyl liquid crystals, phenylcyclohexane liquid crystals, ester liquid crystals, terphine liquid crystals, and terphenyl liquid crystals. enyl), biphenylcyclohexane liquid crystals, pyrimidine liquid crystals, dioxane liquid crystals, bicyclooctane liquid crystals, cubane liquid crystals, etc., and optional additions such as cholesterol chloride, cholesterol nonanoate, cholesterol carbonate, etc. Cholesteric liquid crystals, or under the trade name "C-15", A chiral agent such as "CB-15" (manufactured by Merck), or a ferroelectric liquid crystal such as p-decyloxybenzylidene-p-amino-2-methylbutyl cinnamate.

本發明的液晶配向劑所製作之液晶顯示元件適用於各式向列液晶,如TN、STN、TFT、VA、IPS等之液晶顯示元件。此外,根據所選擇的液晶,亦可使用於強誘電性或反強誘電性等不同的液晶顯示元件。上述液晶顯示元件中,特別適用於IPS型之液晶顯示元件。 The liquid crystal display elements produced by the liquid crystal alignment agent of the present invention are suitable for various types of nematic liquid crystals, such as TN, STN, TFT, VA, IPS and other liquid crystal display elements. In addition, depending on the selected liquid crystal, it can also be used in liquid crystal display elements having different ferroelectric properties, anti-ferroelectric properties, and the like. Among the above-mentioned liquid crystal display elements, the IPS type liquid crystal display element is particularly suitable.

茲以下列實例予以詳細說明本發明,唯並不意謂本發明僅侷限於此等實例所揭示之內容。 The following examples are used to describe the present invention in detail, but it does not mean that the present invention is limited to the content disclosed in these examples.

100‧‧‧液晶顯示元件 100‧‧‧LCD display element

110‧‧‧第一單元 110‧‧‧Unit 1

112‧‧‧第一基板 112‧‧‧The first substrate

114‧‧‧第一導電膜 114‧‧‧The first conductive film

116‧‧‧第一液晶配向膜 116‧‧‧The first liquid crystal alignment film

120‧‧‧第二單元 120‧‧‧Unit 2

122‧‧‧第二基板 122‧‧‧Second Substrate

126‧‧‧第二液晶配向膜 126‧‧‧The second liquid crystal alignment film

130‧‧‧液晶單元 130‧‧‧LCD unit

為讓本發明之上述和其他目的、特徵、優點與實施例能更明顯易懂,所附圖式之詳細說明如下: In order to make the above and other objects, features, advantages and embodiments of the present invention more comprehensible, the detailed description of the accompanying drawings is as follows:

[圖1]繪示根據本發明之一實施例所述之液晶顯示元件的結構示意圖。 [ FIG. 1 ] is a schematic diagram showing the structure of a liquid crystal display element according to an embodiment of the present invention.

合成聚合物(A1)Synthetic polymers (A1)

合成例A1-1-1Synthesis Example A1-1-1

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入0.107克(0.0005莫耳)的如式(2-1)所示之二胺化合物(b1-1-7)、5.353克(0.0495莫耳)的對-二胺苯(b1-2-1)及 80克的N-甲基-2-吡咯烷酮(以下簡稱NMP),並於室溫下攪拌至溶解。接著,加入1.68克(0.0075莫耳)的如式(I-1)所示的化合物(a1-1-1)、9.27克(0.0425莫耳)的苯均四羧酸二酐(a1-2-1)及20克的NMP,並於室溫下反應2小時。反應結束後,將反應溶液倒入1500毫升的水中,以析出聚合物,過濾所得之聚合物,並以甲醇重複進行清洗及過濾之步驟三次。之後,將產物置入真空烘箱中,並以溫度60℃進行乾燥,即可得聚合物(A1-1-1),其配方如表1所示。 A nitrogen inlet, a stirrer, a condenser and a thermometer were installed on a four-neck conical flask with a volume of 500 ml, and nitrogen was introduced. Then, add 0.107 gram (0.0005 mol) of diamine compound (b1-1-7) shown in formula (2-1), 5.353 gram (0.0495 mol) of p-diaminobenzene (b1-2-1) and 80 grams of N-methyl-2-pyrrolidone (hereinafter referred to as NMP), and stirred at room temperature until dissolved. Then, 1.68 grams (0.0075 moles) of compound (a1-1-1), 9.27 grams (0.0425 moles) of pyromellitic dianhydride (a1-2-1) and 20 grams of NMP were added and reacted at room temperature for 2 hours. After the reaction, the reaction solution was poured into 1500 ml of water to precipitate the polymer, and the obtained polymer was filtered, and the steps of washing and filtering were repeated three times with methanol. Afterwards, the product was placed in a vacuum oven and dried at a temperature of 60° C. to obtain the polymer (A1-1-1), whose formula is shown in Table 1.

合成例A1-1-2至A1-1-10及合成比較例A1’-1-1至A1’-1-2Synthesis Examples A1-1-2 to A1-1-10 and Synthesis Comparative Examples A1'-1-1 to A1'-1-2

合成例A1-1-2至A1-1-10及比較合成例A1’-1-1至A1’-1-2使用與合成例A1-1-1之聚合物(A1-1-1)的製作方法相同之製備方法,不同之處在於合成例A1-1-2至A1-1-10及比較合成例A1’-1-1至A1’-1-2改變聚合物中原料的種類與使用量,其配方如表1所示,此處不另贅述。 Synthesis Examples A1-1-2 to A1-1-10 and Comparative Synthesis Examples A1'-1-1 to A1'-1-2 use the same preparation method as the preparation method of the polymer (A1-1-1) in Synthesis Example A1-1-1, the difference is that Synthesis Examples A1-1-2 to A1-1-10 and Comparative Synthesis Examples A1'-1-1 to A1'-1-2 change the types and usage amounts of raw materials in the polymer. repeat.

合成例A1-2-1Synthesis Example A1-2-1

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、加熱器、冷凝管及溫度計,並導入氮氣。然後,加入0.107克(0.0005莫耳)的如式(2-1)所示之二胺化合物(b1-1-7)、5.35克(0.0495莫耳)之對-二胺苯(b1-2-1)及80克的NMP,並於室溫下攪拌至溶解。接著,加入2.24克(0.01莫耳)的如式(I-1)所示的化合物(a1-1-1)、8.72克(0.04莫耳)的苯均四羧酸二酐(a1-2-1)及20克的NMP。室溫下反應 6小時後。反應結束後,加入97克的NMP、2.55克的醋酸酐及19.75克的吡啶至前述之反應液中,升溫至60℃,且持續攪拌2小時,以進行醯亞胺化反應。反應結束後,將反應溶液倒入1500毫升的水中,以析出聚合物,過濾所得之聚合物,並以甲醇重複進行清洗及過濾之步驟三次。之後,將產物置入真空烘箱中,並以溫度60℃進行乾燥,即可得聚合物(A1-2-1),其配方如表1所示。 A nitrogen inlet, a stirrer, a heater, a condenser, and a thermometer were arranged on a four-necked conical flask with a volume of 500 milliliters, and nitrogen was introduced. Then, add 0.107 grams (0.0005 moles) of diamine compound (b1-1-7) shown in formula (2-1), 5.35 grams (0.0495 moles) of p-diaminobenzene (b1-2-1) and 80 grams of NMP, and stir at room temperature until dissolved. Then, 2.24 g (0.01 mol) of compound (a1-1-1) represented by formula (I-1), 8.72 g (0.04 mol) of pyromellitic dianhydride (a1-2-1) and 20 g of NMP were added. reaction at room temperature 6 hours later. After the reaction, 97 g of NMP, 2.55 g of acetic anhydride, and 19.75 g of pyridine were added to the aforementioned reaction solution, the temperature was raised to 60° C., and the stirring was continued for 2 hours to carry out the imidization reaction. After the reaction, the reaction solution was poured into 1500 ml of water to precipitate the polymer, and the obtained polymer was filtered, and the steps of washing and filtering were repeated three times with methanol. Afterwards, the product was placed in a vacuum oven and dried at a temperature of 60° C. to obtain the polymer (A1-2-1), whose formula is shown in Table 1.

合成例A1-2-2至A1-2-4及合成比較例A1’-2-1Synthesis Examples A1-2-2 to A1-2-4 and Synthesis Comparative Example A1'-2-1

合成例A1-2-2至A1-2-4及比較合成例A1’-2-1使用與合成例A1-2-1之聚合物(A1-2-1)的製作方法相同之製備方法,不同之處在於合成例A1-2-2至A1-2-4及比較合成例A1’-2-1改變聚合物中原料的種類與使用量,其配方如表1所示,此處不另贅述。 Synthesis Examples A1-2-2 to A1-2-4 and Comparative Synthesis Example A1'-2-1 use the same preparation method as that of the polymer (A1-2-1) in Synthesis Example A1-2-1. The difference is that Synthesis Examples A1-2-2 to A1-2-4 and Comparative Synthesis Example A1'-2-1 change the types and amounts of raw materials in the polymer. The formulations are shown in Table 1 and will not be repeated here.

合成聚合物(A2)Synthetic polymers (A2)

合成例A2-1-1至A2-1-6Synthesis Examples A2-1-1 to A2-1-6

合成例A2-1-1至A2-1-6使用與合成例A1-1-1之聚合物(A1-1-1)的製作方法相同之製備方法,不同之處在於合成例A2-1-1至A2-1-6改變聚合物中原料的種類與使用量,其配方如表2所示,此處不另贅述。 Synthesis Examples A2-1-1 to A2-1-6 use the same preparation method as that of the polymer (A1-1-1) in Synthesis Example A1-1-1. The difference is that Synthesis Examples A2-1-1 to A2-1-6 change the types and amounts of raw materials in the polymer. The formulations are shown in Table 2, and will not be repeated here.

合成例A2-2-1至A2-2-3Synthesis Examples A2-2-1 to A2-2-3

合成例A2-2-1至A2-2-3使用與合成例A1-2-1之聚合物(A1-2-1)的製作方法相同之製備方法,不同之處在於合成例A2-2-1至A2-2-3改變聚合物中原料的種類與使用量,其配方如表2所示,此處不另贅述。 Synthesis Examples A2-2-1 to A2-2-3 use the same preparation method as that of the polymer (A1-2-1) in Synthesis Example A1-2-1. The difference lies in that Synthesis Examples A2-2-1 to A2-2-3 change the types and amounts of raw materials in the polymer. The formulations are shown in Table 2, and will not be repeated here.

實施例1Example 1

製備液晶配向劑Preparation of liquid crystal alignment agent

秤取100重量份之合成例A1-1-1的聚合物(A1-1-1)、1050重量份之NMP,並於室溫下攪拌混合,即可製得實施例1之液晶配向劑。 The liquid crystal alignment agent of Example 1 was prepared by weighing 100 parts by weight of the polymer (A1-1-1) of Synthesis Example A1-1-1 and 1050 parts by weight of NMP, and stirring and mixing at room temperature.

製備液晶配向膜以及液晶顯示元件Preparation of liquid crystal alignment film and liquid crystal display element

將前述所製得的液晶配向劑旋轉塗佈在玻璃基板上,其中前述玻璃基板上形成有畫素電極,其中前述畫素電極為具有一對ITO電極(電極寬:10μm,電極間隔:10μm,電極高度:50nm)之IPS驅動用電極,該對ITO電極係分別具有櫛齒狀之形狀、且彼此之櫛齒狀部份係以分開並咬合之方式來配置。之後,將塗佈有液晶配向劑的玻璃基板在80℃的加熱板上乾燥5分鐘後,在250℃之熱風循環式烘箱中烘烤60分鐘,以形成膜厚為100nm的塗膜。 The prepared liquid crystal alignment agent was spin-coated on a glass substrate, wherein a pixel electrode was formed on the glass substrate, wherein the pixel electrode was an IPS driving electrode having a pair of ITO electrodes (electrode width: 10 μm, electrode spacing: 10 μm, electrode height: 50 nm), the pair of ITO electrodes respectively had a comb-shaped shape, and the comb-shaped parts of each other were arranged in a manner of separating and occluding. Afterwards, the glass substrate coated with the liquid crystal alignment agent was dried on a hot plate at 80° C. for 5 minutes, and then baked in a hot air circulation oven at 250° C. for 60 minutes to form a coating film with a film thickness of 100 nm.

透過一偏光板,對塗膜面照射波長為254nm的紫外線,以製得有液晶配向膜的基板。接下來,同樣地,在對向基板上形成塗膜並施予配向處理,所述對向基板為未有電極形成但具有高度為4μm之柱狀間隔件的玻璃基板。 Through a polarizing plate, irradiate the surface of the coating film with ultraviolet rays with a wavelength of 254nm to prepare a substrate with a liquid crystal alignment film. Next, similarly, a coating film was formed on an opposite substrate, which is a glass substrate with no electrodes formed but columnar spacers with a height of 4 μm, and subjected to alignment treatment.

上述二個基板為一組,在其中一者上印刷密封劑,而另一者以與液晶配向膜面對且配向方向為0°的方式,黏合二者,之後硬化密封劑以製得空的晶胞。將這個空晶胞以減壓注入法,注入液晶MLC-2041(Merck公司製),並密封注入口,即為實施例1之液晶顯示元件。 The above two substrates form a set, one of which is printed with a sealant, and the other is bonded to face the liquid crystal alignment film with an alignment direction of 0°, and then the sealant is hardened to form an empty unit cell. The empty unit cell was injected into liquid crystal MLC-2041 (manufactured by Merck) by a depressurized injection method, and the injection port was sealed to obtain the liquid crystal display element of Example 1.

將實施例1的液晶顯示元件以後述評價方式進 行評價,其結果如表3所示。 The liquid crystal display element of embodiment 1 was evaluated in the following manner The evaluation was carried out, and the results are shown in Table 3.

實施例2至26及比較例1至5Examples 2 to 26 and Comparative Examples 1 to 5

實施例2至26及比較例1至5使用與實施例1之液晶配向劑相同之製備方法,不同之處在於實施例2至26及比較例1至5改變液晶配向劑中原料的種類及使用量,其配方及評價結果分別如表3及表4所示,此處不另贅述。 Examples 2 to 26 and Comparative Examples 1 to 5 use the same preparation method as the liquid crystal alignment agent of Example 1. The difference lies in that the types and usage amounts of the raw materials in the liquid crystal alignment agent are changed in Examples 2 to 26 and Comparative Examples 1 to 5. The formulations and evaluation results are shown in Table 3 and Table 4 respectively, and will not be repeated here.

評價方式Evaluation method

電荷消除耐光性Charge Elimination Light Fastness

將利用實施例1至26及比較例1至5所製得之經照射波長為254nm的紫外線配向之液晶顯示元件分別以3伏特的直流電壓施加30分鐘,接著以電氣測量機台(TOYO Corporation製,型號Model 6254)測量液晶顯示元件於電壓解除後之積蓄電壓(VR1)及電壓解除後15分鐘之積蓄電壓(VR2),經下式(1)計算出積蓄電荷消除坡度(VS),並依據以下基準進行評價電荷消除耐光性。其中,照射波長254nm的紫外線後的積蓄電荷消除坡度愈高表示該液晶顯示元件的電荷消除耐光性愈佳: Apply a DC voltage of 3 volts to the aligned liquid crystal display elements prepared in Examples 1 to 26 and Comparative Examples 1 to 5 and irradiated with ultraviolet light having a wavelength of 254 nm for 30 minutes, then use an electrical measuring machine (manufactured by TOYO Corporation, model Model 6254) to measure the accumulated voltage (V R1 ) of the liquid crystal display element after the voltage is released and the accumulated voltage (V R2 ) 15 minutes after the voltage is released, and the accumulated charge elimination slope is calculated by the following formula (1) (V S ), and the charge erasing light resistance was evaluated on the basis of the following criteria. Among them, the higher the accumulated charge elimination slope after irradiating ultraviolet rays with a wavelength of 254nm, the better the charge elimination and light resistance of the liquid crystal display element:

Figure 108143269-A0101-12-0053-152
Figure 108143269-A0101-12-0053-152

※:75%<VS ※: 75%<V S

◎:70%<VS≦75% ◎: 70%<V S ≦75%

○:65%<VS≦70% ○: 65%<V S ≦70%

△:60%<VS≦65% △: 60%<V S ≦65%

×:VS≦60%。 ×: V S ≦60%.

預傾角Pretilt

根據T.J.謝弗(T.J.Scheffer)等人於1980年發表於《應用物理學雜誌》(Journal of Applied Physics,J.Appl.Phys.)第19期第2013頁所記載的方法,利用He-Ne雷射光之結晶旋轉法測量實施例1至26及比較例1至5所製得之液晶顯示元件的中心點之預傾角,其結果如表3及表4所示。 According to the method described on page 2013 of the 19th issue of Journal of Applied Physics (J.Appl.Phys.) published by T.J. Scheffer (T.J.Scheffer) et al. in 1980, the pretilt angle of the center point of the liquid crystal display elements prepared in Examples 1 to 26 and Comparative Examples 1 to 5 was measured by the crystal rotation method of He-Ne laser light. The results are shown in Table 3 and Table 4.

根據表3及表4,若液晶配向劑中聚合物(A)所包含之第一聚合物(A1)未使用特定的四羧酸二酐組份(a1)及二胺組份(b1)來合成時,所製得之液晶顯示元件的電荷消除耐光性不佳。 According to Table 3 and Table 4, if the first polymer (A1) included in the polymer (A) in the liquid crystal alignment agent is not synthesized using a specific tetracarboxylic dianhydride component (a1) and diamine component (b1), the resulting liquid crystal display device has poor charge elimination and light resistance.

進一步而言,當二胺組份(b1)中之二胺化合物(b1-1)具有如式(II)所示之結構,且式(II)中之X3代表碳數為3至10的支鏈烷基時,可進一步提升液晶顯示元件的電荷消除耐光性。 Further, when the diamine compound (b1-1) in the diamine component (b1) has a structure as shown in formula (II), and X in formula ( II ) represents a branched chain alkyl group with a carbon number of 3 to 10, the charge elimination and light resistance of the liquid crystal display element can be further improved.

另,當液晶配向劑中聚合物(A)包含由特定的四羧酸二酐組份(a2)及二胺組份(b2)反應所製得之第二聚合物(A2)時,可進一步提升液晶顯示元件的電荷消除耐光性。再者,當二胺組份(b2)具有含羧酸基之二胺化合物(b2-1)時,可再進一步提升液晶顯示元件的電荷消除耐光性。 In addition, when the polymer (A) in the liquid crystal alignment agent contains the second polymer (A2) prepared by the reaction of the specific tetracarboxylic dianhydride component (a2) and the diamine component (b2), the charge-eliminating light resistance of the liquid crystal display element can be further improved. Furthermore, when the diamine component (b2) has a carboxylic acid group-containing diamine compound (b2-1), the charge-eliminating light resistance of the liquid crystal display device can be further improved.

此外,當二胺組份(b2)具有含羧酸基之二胺化合物(b2-2)時,可再進一步提升液晶顯示元件的電荷消除耐光性。 In addition, when the diamine component (b2) has a carboxylic acid group-containing diamine compound (b2-2), the charge-eliminating light resistance of the liquid crystal display device can be further improved.

雖然本發明已以數個實施例揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常 知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 Although the present invention has been disclosed as above with several embodiments, it is not intended to limit the present invention. Those who are knowledgeable can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be defined by the scope of the appended patent application.

Figure 108143269-A0101-12-0056-153
Figure 108143269-A0101-12-0056-153

Figure 108143269-A0101-12-0057-154
Figure 108143269-A0101-12-0057-154

Figure 108143269-A0101-12-0058-155
Figure 108143269-A0101-12-0058-155

Figure 108143269-A0101-12-0059-156
Figure 108143269-A0101-12-0059-156

100‧‧‧液晶顯示元件 100‧‧‧LCD display element

110‧‧‧第一單元 110‧‧‧Unit 1

112‧‧‧第一基板 112‧‧‧The first substrate

114‧‧‧第一導電膜 114‧‧‧The first conductive film

116‧‧‧第一液晶配向膜 116‧‧‧The first liquid crystal alignment film

120‧‧‧第二單元 120‧‧‧Unit 2

122‧‧‧第二基板 122‧‧‧Second Substrate

126‧‧‧第二液晶配向膜 126‧‧‧The second liquid crystal alignment film

130‧‧‧液晶單元 130‧‧‧LCD unit

Claims (17)

一種液晶配向劑,包含: A liquid crystal alignment agent, comprising: 聚合物(A),包含第一聚合物(A1),且該第一聚合物(A1)係由四羧酸二酐組份(a1)及二胺組份(b1)反應而製得,其中該四羧酸二酐組份(a1)包含至少一種如下式(I)所示之四羧酸二酐化合物(a1-1): The polymer (A) comprises a first polymer (A1), and the first polymer (A1) is prepared by reacting a tetracarboxylic dianhydride component (a1) and a diamine component (b1), wherein the tetracarboxylic dianhydride component (a1) comprises at least one tetracarboxylic dianhydride compound (a1-1) represented by the following formula (I):
Figure 108143269-A0101-13-0001-167
Figure 108143269-A0101-13-0001-167
於該式(I)中,R1至R4各自獨立地代表氫原子、鹵素原子、碳數為1至6的烷基、碳數為2至6的烯基、碳數為2至6的炔基、含有氟原子且碳數為1至6的一價有機基團或苯基,R1至R4為相同或不相同,且R1、R2、R3及R4之至少一者不為氫原子;以及其中該二胺組份(b1)包含至少一種如下式(II)所示之二胺化合物(b1-1): In the formula (I), R 1 to R 4 each independently represent a hydrogen atom, a halogen atom, an alkyl group with a carbon number of 1 to 6, an alkenyl group with a carbon number of 2 to 6, an alkynyl group with a carbon number of 2 to 6, a monovalent organic group or a phenyl group containing a fluorine atom and a carbon number of 1 to 6, R 1 to R 4 are the same or different, and at least one of R 1 , R 2 , R 3 and R 4 is not a hydrogen atom; and wherein the diamine component (b1) contains at least one diamine compound (b1-1) represented by the following formula (II):
Figure 108143269-A0101-13-0001-168
Figure 108143269-A0101-13-0001-168
於該式(II)中,X1代表O、COO、OCO、CONH或NHCO,環X2代表苯環或環己烷,以及X3代表碳數為1至10的直鏈烷基或碳數為3至10的支鏈烷基;以及 In this formula (II), X 1 represents O, COO, OCO, CONH or NHCO, ring X 2 represents a benzene ring or cyclohexane, and X 3 represents a straight-chain alkyl group with a carbon number of 1 to 10 or a branched chain alkyl group with a carbon number of 3 to 10; and 一溶劑(B)。 - Solvent (B).
如申請專利範圍第1項所述之液晶配向 劑,其中於該式(II)中,X3代表碳數為3至10的支鏈烷基。 The liquid crystal alignment agent as described in claim 1, wherein in the formula (II), X 3 represents a branched chain alkyl group with 3 to 10 carbon atoms. 如申請專利範圍第1項所述之液晶配向劑,其中該聚合物(A)包含第二聚合物(A2),該第二聚合物(A2)係由四羧酸二酐組份(a2)與二胺組份(b2)反應而製得。 The liquid crystal alignment agent as described in claim 1, wherein the polymer (A) includes a second polymer (A2), and the second polymer (A2) is prepared by reacting a tetracarboxylic dianhydride component (a2) with a diamine component (b2). 如申請專利範圍第3項所述之液晶配向劑,其中該二胺組份(b2)包含至少一種如下式(III)所示之二胺化合物(b2-1): The liquid crystal alignment agent described in claim 3 of the patent application, wherein the diamine component (b2) contains at least one diamine compound (b2-1) represented by the following formula (III):
Figure 108143269-A0101-13-0002-169
Figure 108143269-A0101-13-0002-169
於該式(III)中,W1各自獨立地代表氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基或乙醯胺基、氟原子、氯原子或溴原子,W2各自獨立地代表碳數為1至3的烷基,m1各自獨立地代表0至3的整數,且m2代表0至4的整數。 In the formula (III), W1 each independently represents a hydrogen atom, an alkyl group having a carbon number of 1 to 10, an alkoxy group or an acetamide group having a carbon number of 1 to 10, a fluorine atom, a chlorine atom or a bromine atom, W2 each independently represents an alkyl group having a carbon number of 1 to 3, each m1 independently represents an integer of 0 to 3, and m2 represents an integer of 0 to 4.
如申請專利範圍第3項所述之液晶配向劑,其中該二胺組份(b2)包含至少一種含羧酸基之二胺化合物(b2-2)。 The liquid crystal alignment agent described in claim 3, wherein the diamine component (b2) contains at least one carboxylic acid group-containing diamine compound (b2-2). 如申請專利範圍第4項所述之液晶配向 劑,其中於該式(III)中,W1各自獨立地代表氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基或乙醯胺基。 The liquid crystal alignment agent described in item 4 of the scope of the patent application, wherein in the formula (III), W 1 each independently represent a hydrogen atom, an alkyl group with 1 to 10 carbons, an alkoxy group with 1 to 10 carbons, or an acetamide group. 如申請專利範圍第5項所述之液晶配向劑,其中該含羧酸基之二胺化合物(b2-2)包含下式(IV)所示之化合物: The liquid crystal alignment agent as described in item 5 of the scope of the patent application, wherein the carboxylic acid group-containing diamine compound (b2-2) includes a compound represented by the following formula (IV):
Figure 108143269-A0101-13-0003-170
Figure 108143269-A0101-13-0003-170
於該式(IV)中,Y代表含碳數為6至30的芳香環之有機基團,且n代表1至4的整數。 In the formula (IV), Y represents an organic group having an aromatic ring having 6 to 30 carbons, and n represents an integer of 1 to 4.
如申請專利範圍第7項所述之液晶配向劑,其中該含羧酸基之二胺化合物(b2-2)係選自於由下式(IV-1)至式(IV-5)所組成之一族群之至少一者: The liquid crystal alignment agent described in claim 7 of the patent application, wherein the carboxylic acid group-containing diamine compound (b2-2) is at least one member selected from the group consisting of the following formula (IV-1) to formula (IV-5):
Figure 108143269-A0101-13-0003-171
Figure 108143269-A0101-13-0003-171
Figure 108143269-A0101-13-0003-172
Figure 108143269-A0101-13-0003-172
Figure 108143269-A0101-13-0003-173
Figure 108143269-A0101-13-0003-173
Figure 108143269-A0101-13-0004-174
Figure 108143269-A0101-13-0004-174
Figure 108143269-A0101-13-0004-175
Figure 108143269-A0101-13-0004-175
於該式(IV-1)至該式(IV-5)中,Y1及Y3各自獨立地代表單鍵、-CH2-、-C2H4-、-C(CH3)2-、-CF2-、-C(CF3)2-、-O-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-; In the formula (IV-1) to the formula (IV-5), Y 1 and Y 3 each independently represent a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, -CF 2 -, -C(CF 3 ) 2 -, -O-, -CO-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -CON(CH 3 )- or -N( CH 3 ) CO-; Y2代表碳數為1至5的直鏈烷基或碳數為1至5的支鏈烷基; Y represents a straight-chain alkyl group with 1 to 5 carbons or a branched chain alkyl group with 1 to 5 carbons; n1及n7各自獨立地代表1至4的整數; n1 and n7 each independently represent an integer from 1 to 4; n2及n3各自獨立地代表0至4的整數,且n2與n3之總和為1至4的整數;以及 n2 and n3 each independently represent an integer of 0 to 4, and the sum of n2 and n3 is an integer of 1 to 4; and n4、n5及n6各自獨立地代表1至5的整數。 n4, n5, and n6 each independently represent an integer of 1 to 5.
如申請專利範圍第1項所述之液晶配向劑,其中基於該四羧酸二酐組份(a1)的總使用量為100莫耳,該式(I)所示之該四羧酸二酐化合物(a1-1)的使用量為20莫耳至100莫耳。 The liquid crystal alignment agent as described in item 1 of the scope of the patent application, wherein based on the total usage amount of the tetracarboxylic dianhydride component (a1) being 100 moles, the usage amount of the tetracarboxylic dianhydride compound (a1-1) represented by the formula (I) is 20 moles to 100 moles. 如申請專利範圍第1項所述之液晶配向劑,其中基於該二胺組份(b1)的總使用量為100莫耳,該 式(II)所示之該二胺化合物(b1-1)的使用量為1莫耳至20莫耳。 The liquid crystal alignment agent as described in item 1 of the scope of the patent application, wherein the total usage amount of the diamine component (b1) is 100 moles, the The diamine compound (b1-1) represented by the formula (II) is used in an amount of 1 mol to 20 mol. 如申請專利範圍第4項所述之液晶配向劑,其中基於該二胺組份(b2)的總使用量為100莫耳,該式(III)所示之該二胺化合物(b2-1)的使用量為5莫耳至75莫耳。 The liquid crystal alignment agent described in claim 4 of the patent application, wherein based on the total usage amount of the diamine component (b2) is 100 moles, the usage amount of the diamine compound (b2-1) represented by the formula (III) is 5 moles to 75 moles. 如申請專利範圍第5項所述之液晶配向劑,其中基於該二胺組份(b2)的總使用量為100莫耳,該含羧酸基之二胺化合物(b2-2)的使用量為25莫耳至95莫耳。 The liquid crystal alignment agent as described in item 5 of the patent application, wherein based on the total usage amount of the diamine component (b2) being 100 moles, the usage amount of the carboxylic acid group-containing diamine compound (b2-2) is 25 moles to 95 moles. 如申請專利範圍第3項所述之液晶配向劑,其中基於該聚合物(A)之總使用量為100重量份,該第一聚合物(A1)之使用量為10重量份至90重量份,且該第二聚合物(A2)之使用量為10重量份至90重量份。 The liquid crystal alignment agent as described in item 3 of the patent application, wherein based on the total usage amount of the polymer (A) being 100 parts by weight, the usage amount of the first polymer (A1) is 10 parts by weight to 90 parts by weight, and the usage amount of the second polymer (A2) is 10 parts by weight to 90 parts by weight. 如申請專利範圍第1項所述之液晶配向劑,其中基於該聚合物(A)的使用量為100重量份,該溶劑(B)的使用量為800重量份至4000重量份。 The liquid crystal alignment agent as described in claim 1, wherein the amount of the solvent (B) is 800 to 4000 parts by weight based on 100 parts by weight of the polymer (A). 如申請專利範圍第1項所述之液晶配向劑,其中該液晶配向劑經一預烤處理、一後烤處理及一光配向處理後形成一液晶配向膜,該液晶配向膜之預傾角為 0°至3°。 The liquid crystal alignment agent described in item 1 of the scope of the patent application, wherein the liquid crystal alignment agent forms a liquid crystal alignment film after a pre-baking treatment, a post-baking treatment and a photo-alignment treatment, and the pre-tilt angle of the liquid crystal alignment film is 0° to 3°. 一種液晶配向膜,係利用如申請專利範圍第1項至第15項之任一項所述之液晶配向劑所形成。 A liquid crystal alignment film is formed by using the liquid crystal alignment agent described in any one of the first to fifteenth items of the scope of the patent application. 一種液晶顯示元件,包含如申請專利範圍第16項所述之液晶配向膜。 A liquid crystal display element, including the liquid crystal alignment film described in item 16 of the scope of application.
TW108143269A 2019-11-27 2019-11-27 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element TWI808279B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW108143269A TWI808279B (en) 2019-11-27 2019-11-27 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN202011240108.XA CN112852446B (en) 2019-11-27 2020-11-09 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108143269A TWI808279B (en) 2019-11-27 2019-11-27 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Publications (2)

Publication Number Publication Date
TW202120592A TW202120592A (en) 2021-06-01
TWI808279B true TWI808279B (en) 2023-07-11

Family

ID=75995456

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108143269A TWI808279B (en) 2019-11-27 2019-11-27 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Country Status (2)

Country Link
CN (1) CN112852446B (en)
TW (1) TWI808279B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI859005B (en) * 2023-11-23 2024-10-11 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107089956A (en) * 2016-02-18 2017-08-25 Jnc株式会社 Diamines, polyamic acid or derivatives thereof, aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells
TW201930468A (en) * 2017-12-29 2019-08-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102159410B1 (en) * 2013-03-14 2020-09-23 제이엔씨 주식회사 Liquid crystal aligning agents and liquid crystal display devices
TW201912768A (en) * 2017-08-29 2019-04-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP2021015134A (en) * 2017-11-29 2021-02-12 日産化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107089956A (en) * 2016-02-18 2017-08-25 Jnc株式会社 Diamines, polyamic acid or derivatives thereof, aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells
TW201930468A (en) * 2017-12-29 2019-08-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Also Published As

Publication number Publication date
CN112852446B (en) 2023-11-17
TW202120592A (en) 2021-06-01
CN112852446A (en) 2021-05-28

Similar Documents

Publication Publication Date Title
JP5273357B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5532195B2 (en) Liquid crystal aligning agent and liquid crystal display element
CN104342171B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element containing liquid crystal alignment film
TWI740043B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP5013106B2 (en) Liquid crystal aligning agent and liquid crystal display element
CN105087019B (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
JP2010002880A (en) Liquid crystal alignment agent and liquid crystal display element
JP2019003188A (en) Method for producing liquid crystal alignment film and liquid crystal display element
JP5282869B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI808279B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP4539836B2 (en) Liquid crystal aligning agent and horizontal electric field type liquid crystal display element
TWI874658B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP5316752B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW201912768A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
CN115595159A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display module
JP4788898B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5246399B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP2009294281A (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TWI869411B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP4788890B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI834894B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP5339062B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP2008203537A (en) Liquid crystal aligning agent and liquid crystal display element
CN115368914A (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
CN118011690A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display component